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Abstract
For many years, molecularly imprinted polymers (MIPs) have been 
described as "plastic antibodies", yet even some modern examples 
cannot approach the true binding affinity and specificity of monoclonal 
antibodies. This project sought to include within the imprinted site a 
short peptide sequence isolated from a phage display library with high 
affinity and specificity. A system is hypothesised in which synergism 
between the robust nature of the polymer and the binding affinity and 
specificity of the peptide may be exploited.
Peptide phage display is a technique that can rapidly enrich binding 
peptides from a combinatorial library of over 109 unique moieties. Initial 
studies attempted to isolate peptides with high affinity and specificity to 
propranolol from this library. However, when several methodologies 
failed to demonstrate any binding effect, a peptide was selected from 
the literature that had been found to bind the fluorophore Texas Red. 
The peptide was immobilised to a Merrifield Resin support, its binding 
properties thoroughly assessed, and a polymerisation protocol was 
developed using living radical polymerisation.
Preliminary studies suggested that when peptide-functionalised resin 
was washed in ethanol, no binding to Texas Red was evident, whereas
once a protective polymer shell was formed, the peptide retained a 
binding conformation and affinity for Texas Red was slightly increased. 
This was, however, at the expense of binding capacity, which fell 
dramatically. Whilst the evidence presented here is by no means 
complete, it provides proof-of-principle for a functional peptide- 
molecularly-imprinted polymer. Further work in this area may lead to the 
development of a truly biomimetic artificial antibody: the plastibody.
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Chapter 1
General In t roduct ion
“Take the first step in faith.
You don't have to see the whole staircase, 
just take the first step. ”
Dr. Martin Luther King Jr.
1.1 The Molecularly Imprinted Polymer
The concept of the molecularly 
imprinted polymer (MIP) is the 
creation of a plastic cast of a 
given target molecule.
Functional monomers with 
complementary functionality are 
selected that should interact 
with functional groups on the 
target molecule. Following the
addition of a cross-linkable monomers (1) which are known to interact (2), an
excess of cross-linking monomer, and 
conditions to provoke polymerisation (3), 
monomer, the mixture is resulting in imprinted binding pocket (4).
polymerised. The resulting polymer has a binding pocket that will
recognise the target to which the MIP was initially created. While the
aim is for absolute specificity to the target molecule, the MIP will also
Figure 1: Basic concept of the imprinted 
polymer: a template is exposed to functional
1
recognise certain related compounds (reviewed in (Alexander et al., 
2006, Haupt and Mosbach, 1999, Hillberg et al., 2005, Ansell, 2005)).
The concept of the molecular imprint is not new technology. Initial 
reports in the 1930s were made (Polyakov, 1931) when silica gels were 
cast in the presence or absence of other molecules in solution. The 
resulting gels were found to have higher affinity for solutes that had 
been present during casting, compared to solutes that had not been 
previously exposed to the silica gels.
These early examples were inorganic systems. The first example of an 
imprinted organic polymer was presented in the early 1970s (Wulff et 
al., 1973) using a covalent imprinting approach. This paved the way for 
the first demonstration of what is now termed non-covalent imprinting in 
an organic polymer (Arshady and Mosbach, 1981), although the term 
used at the time was “host-guest” polymerisation.
An example in which the synthetic polymer was used to replace 
antibodies in a ligand binding assay was presented in the early 1990s 
(Vlatakis et al., 1993) in which MIPs were created with theophylline or 
diazepam as templates. These polymers showed strong binding in a 
radio-labelled ligand-binding assay and were sufficient to measure drug 
levels in human serum. MIP formation schematic is shown in Figure 2.
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Figure 2: Schematic representation of the preparation of MIP to theophylline using 
methacrylic acid functional monomer, adapted from (Vlatakis et al., 1993).
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In a more recent example (Busi et al., 2004), an acrylic resin was 
imprinted with a transition state analogue for the Diels-Alder reaction 
(an organic chemical reaction -  specifically cycloaddition). The authors 
showed that the MIP or “plastic antibody” was able to catalyse this 
reaction with an efficiency comparable to that of a monoclonal antibody 
which has been recently developed (Haupt and Mosbach, 2000) to 
catalyse this same reaction; this example highlights the potential of 
plastic enzymes.
As the field developed, the concept of this “plastic antibody” has 
become ever more achievable. Recent advances in imprinting 
technology include the immobilization of MIP particles/beads on the 
sensor chips of a quartz crystal microbalance (QCM), producing 
piezoelectric sensors (Uludag et al., 2007). Two further reports have 
also demonstrated MIPs raised against glucose (Seong et al., 2002) 
and nateglinide (Yin et al., 2005), to display dissociation constants (KD) 
at millimolar concentrations (1.6mM and 7.4mM respectively). 
Physiologically safe nanoparticles have even been tested in vivo 
showing high affinity for a component of bee venom (Hoshino et al., 
2010).
1.1.1 Methods o f Imprinting
In general, there are two main forms of the molecular imprinting 
process: covalent and non-covalent imprinting. However, an
amalgamation of the two has also been demonstrated in the semi- 
covalent approach.
1.1.1.1 Covalent Imprinting
When this method is employed, the goal is to control the arrangement 
of functional groups within the binding cavity to best effect, thus 
ensuring the tightest fit of target structure in the binding site.
The earliest example (WulfF et al., 1973) involved the imprinting of 
functional monomers with boronic acid functional groups. Boronic add 
undergoes rapid and reversible reaction with diols, therefore once the 
template is recognised it is covalently attached to the polymer until the 
system is washed with either water or methanol to detach the template.
A more recent example, illustrated in Figure 3, shows the covalent 
imprinting of a dopamine analogue, which after hydrolysis of the esters 
and reduction of the disulfide bond resulted in a binding site for 
dopamine.
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Figure 3: Covalent imprinting of dopamine adapted from (Takeuchi et al., 2006), including
the structure of dopamine (inset)
Using a covalent imprinting technique can place functional groups so 
accurately within a binding site that two or more templates can be 
recognised simultaneously, indeed they may even interact. In a recent 
example (Carlson et al., 2006) a chemical sensor for fluorene was 
produced such that the binding pocket of the MIP could covalently bind 
to a fluorophore which underwent alterations in spectroscopic properties 
when in close proximity to fluorene.
Rebinding to this type of polymer can either be through the reformation 
of a covalent bond, or can be non-covalent. This non-covalent binding 
to a covalently imprinted polymer is sometimes referred to as the semi- 
covalent approach (Alexander et al., 2006).
1.1.1.2 Semi-covalent Imprinting
When the semi-covalent approach is undertaken, the template is
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covalently attached to a polymerisable group as in the covalent 
strategy, with binding becoming available after cleavage of the 
template. There are two variations on this method: template and 
monomer are directly connected (Caro et al., 2002), or the template and 
monomer are connected via a spacer group (Whitcombe et al., 1995).
This sacrificial-spacer method provides more space within the imprinted 
recognition site than previous methods, allowing for greater diffusion 
into and out of the binding sites. Imprinting using this method has been 
applied in several studies (Hwang and Lee, 2002, Percival et al., 2002, 
Petcu et al., 2001) and is still in use today (Qi et al., 2010).
1.1.1.3 Non-covalent Imprinting
The basic drive behind imprinted polymer science has always been the 
pursuit of a material that mimics natural antibodies whilst being 
constructed artificially. When the antibody binds to its target molecule, 
or “template”, covalent bonds are not formed; instead the binding is via 
a series of non-covalent interactions. With this in mind, the non-covalent 
imprinting approach, in which binding can nevertheless be specific yet 
reversible, becomes an obvious choice for the production of MIPs (Caro 
et al., 2002) as the interactions between the template and the functional 
monomers are the same as those between the final polymer and the 
template when re-binding, pioneered by the Mosbach group (Arshady 
and Mosbach, 1981). The non-covalent approach was shown briefly in
Figure 2.
The quality of the final MIP hinges upon the quality of the complexes 
formed in the pre-polymerisation solution, and therefore the strength of 
the template-monomer interaction (Chianella et al., 2002, Karim et al.,
2005).
1.1.2 Components of an Imprinted Polymer
When constructing a polymer several components are essential. Firstly, 
there must be a functional monomer. This is a compound which, while 
showing some level of interaction with the template (ionic, hydrogen- 
bonds, van der Waals), should also have a separate function group 
capable of supporting polymerisation. An example would be methacrylic 
acid (MAA) which is used extensively in imprinting science (Dai et al., 
2010, Liu etal., 2010).
The template molecule and the monomer of choice must then be 
dispersed in a solvent. It is this dispersion in a porogenic solvent that 
should result in the macroporous structure of the final polymer allowing
OH
Figure 4: Methacrylic acid (MAA).
elution of the template and indeed rebinding. The correct choice of 
porogen is essential to producing the intended quality of polymer (pore 
size distribution, structure, swelling properties) (Haginaka et al., 2008).
Polymerisation initiators can take several forms, most commonly 
activated by either heat or UV light (O'Shannessy et al., 1989). An 
example of a widely used polymerisation initiator is 
2,2'azobisisobutyronitrile (AIBN) which generates free radicals upon 
exposure to UV light (Urraca et al., 2008).
1.1.2.1 Functional Monomers
While it is relatively easy to predict molecular interactions in terms of 
hydrogen bonding or pi-pi stacking, the three-dimensional, constantly 
shifting solution complexation can be a far more complicated issue, 
although, one which can be simulated using molecular dynamics 
studies (Karlsson et al., 2009). Whilst recent developments suggest a 
computational approach to the design of an imprinted polymer may 
soon be practical (Dong et al., 2009), often the design of MIPs 
necessitates the performing of a series of explorative experiments in 
which a range of monomers are tested against the desired template at a
CN CN
Figure 5: 2,2*-azot>isisobutyronitrile (AIBN).
range of monomer-to-template ratios whilst observing for some change 
in the system indicative of some form of interaction occurring (Lulinski 
and Maciejewska, 2009, Feas et al., 2009).
In the case of molecules that fluoresce (whether intended as the 
template or as a functional monomer leading to a fluorescent MIP), 
simply a shift in the peak fluorescence, or indeed fluorescence 
quenching may be enough to indicate interaction with the fluorophore 
(Rathbone and Bains, 2005). Other methods to determine complexation 
include via NMR titration (Athikomrattanakul et al., 2009, Takeuchi et 
al., 2000) and UV spectroscopy (Svenson et al., 1998). Essentially, the 
hydrogen atoms responsible for hydrogen bond donation should shift on 
an NMR spectrum as nearby structures cause a change in resonance; 
likewise, hydrogens neighbouring carbonyl groups, for example, may 
also shift as hydrogen bonds are accepted. With this in mind, a range of 
monomer-to-template ratios can be examined in search of a 
combination which results in the greatest spectroscopic shift.
1.1.3 Methods of Polymerisation
A number of approaches have been used to prepare MIPs. These 
include bulk polymerisation, suspension polymerisation, precipitation, 
emulsion, and surface grafting, which would include living systems such 
as iniferter-mediated polymerisation (Fairhurst et al., 2004, Alexander et 
al., 2006).
1 0
1.1.3.1 Bulk Polym erisation
When Polyakov (Polyakov, 1931) first stumbled across the imprinting 
phenomenon, he was casting silica gels. Therefore, the structure of the 
system was one, large, single, inorganic unit. When this concept was 
followed up by other researchers, a similar bulk-production method was 
employed with grinding and sieving of the block polymer down to 
smaller units which could be assessed for their binding affinity 
(Leonhardt and Mosbach, 1987).
1.1.3.2 Precipitation Polym erisation
In this type of system, a polymer is formed which is insoluble in the pre­
polymerisation mixture. An example of beads produced by precipitation 
polymerisation is shown in Figure 6 (Wang et al., 2003) in which 
approximately 5pm MIP beads were produced which selectively bound 
theophylline.
Figure 6: MIP beads approx 5pm diameter formed via precipitation polymerisation (SEM
micrograph) (Wang et al., 2003).
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1.1.3.3 Emulsion/Suspension Polymerisation
Emulsion polymerisation can be advantageous in generating polymer 
beads of uniform size. In this instance the pre-polymerisation mixture is 
an emulsion with small droplets of monomer (usually the oil phase) 
suspended throughout the solvent (usually aqueous) (Vaihinger et al., 
2002), although there are examples of the inverse (Mayes and 
Mosbach, 1996), termed suspension polymerisation.
One of the overriding issues with the older bulk polymerisation method 
is the loss of binding sites, both in terms of restricted access to those 
sites within the solid construct, and damage to binding sites when the 
polymer is processed (e.g. milling). Whilst suspension or precipitation 
polymerisation protocols go some way toward resolving this, provided 
the resultant beads are sufficiently porous, some binding sites will 
remain relatively inaccessible (Wei and Mizaikoff, 2007).
Bulk or suspension polymers as catalytic agents were compared 
(Strikovsky et al., 2000) in which polymerisation mixtures were identical 
(ethylenedimethacrylate (EDMA), methyl methacrylate (MMA), N,N’- 
diethyl(4-vinylphenyl)amidine (DEVPA), and diphenylphosphate (DPP) 
as template, with acetonitrile (MeCN), cyclohexanol-n-dodecanol, or 
toluene as porogen) yet the product was either monodisperse beads or 
a block polymer requiring grinding and sieving. Assessment of both 
polymers gave comparable binding and catalytic effects.
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1.1.3.5 Surface Grafting
As the technology advances, a further option available to the imprinting 
polymer chemist is that of grafting polymers onto solid supports. MIPs 
can be generated from silica supports with free-radical initiators 
immobilised to the surface, thus producing controllable thin films of 
polymer (Sulitzky et at., 2001). A further advancement of this was seen 
in which a dithiocarbamate iniferter was grafted to a polystyrene bead 
(Qin et al., 2009), shown in Figure 7.
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Figure 7: Schematic representation of chloromethylated polystyrene beads with 
dithiocarbamate iniferter-mediated polymerisation using lysozyme as template, adapted 
from Qin et al (Qin et al., 2009), showing functionalisation of chloromethylated resin with 
a dithiocarbamate iniferter (1), subsequent activation of the iniferter with UV (2), and the 
resulting molecularly imprinted system (3).
The principle concept of the iniferter is that a single molecular species 
may initiate free-radical polymerisation, transfer the radical through the 
growing polymer, and subsequently terminate polymerisation (Otsu et 
al., 1989).
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Figure 8: Illustration of diethyldithiocarbamate iniferter, showing iniferter-functionalised 
moiety (A), the more reactive radical species (B). and the less reactive (C).
The radical free in solution (C) in Figure 8 is far less reactive than that 
immobilised to the surface as the radical can distribute across the CS2 
system, unlike the methyl radical (B). This results in controlled polymer 
growth from the surface, ending when the UV light is extinguished and 
radical C recombines with B.
A direct comparison of ground, beaded, and silica-grafted MIPs, when 
applied as HPLC stationary phases found that, interestingly, “ground 
monolithic imprinted polymer was still the best “all-round” performer for 
enantiomeric separations of a number of (3-blockers by HPLC” 
(Fairhurst et al., 2004), although the beaded material was the most 
efficient to synthesise and gave improved peak shape. In the same 
study the authors also produced silica-grafted material, which, whilst 
taking the longest to manufacture, and not allowing enantiomeric 
separation of four of the nine compounds tested, allowed higher 
resolution of more strongly retained compounds in a relatively short 
period of time.
An important distinction must be made between surface-initiated
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polymerisation, which results in very thin films grown from the surface, 
and solution-initiated polymerisation, in which the polymer can be 
grafted to a surface (Kato et al., 2003). The latter can often result in 
very thick polymer layers.
1.1.3.6 Hierarchical Imprinting
The fundamental concept of the hierarchical imprint is to immobilise the 
template on a support that can subsequently be degraded, perform 
polymerisation, and then remove the support-tempiate complex (Titirici 
and Sellergren, 2004). In this situation it is possible to control to some 
degree the spacing of functional binding pockets in the finished polymer 
(Wu et al., 2008). A typical example in which multiple types of binding 
site were produced hierarchically within a single polymer is presented 
by (Dai, 2001) in which metal ions were imprinted along with surfactant 
micelles. This resulted in imprints of different sizes and functions within 
a single silica matrix.
Another approach makes use of porous silica particles containing 
immobilised templates. The pores are filled with the polymerisation 
mixture, polymerised, and the silica moulds dissolved. This results in a 
porous spherical MIP bead with recognition sites throughout (Titirici and 
Sellergren, 2004).
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1.1.4 Biological Molecules and MIPs
More recently, researchers in molecularly imprinted polymer science 
have found interest in the application of these systems to biological 
molecules such as peptides (Yoshimatsu et al., 2009, Papaioannou et 
al., 2008) including synthetic peptide receptors incorporating metal ions 
into the binding matrix (Hart and Shea, 2001), proteins (Hansen, 2007), 
and even viruses (Bolisay et al., 2007).
Larger proteins present a problem to the current systems for molecular 
imprinting, however, one method (termed the “epitope approach”) 
(Nishino et al., 2006) allows imprinting of short peptide constituents of 
the protein with a view toward recognising the protein as a whole after 
polymerisation.
A further study was produced recently (Hoshino et al., 2010) in which 
melittin (a component of bee venom) was imprinted into polymer 
nanoparticles which were then injected into living mice. When the mice 
were then inoculated with melittin, mortality and peripheral toxicity 
symptoms were greatly reduced, demonstrating that the MIP 
nanoparticles were capable of capturing and facilitating the clearance of 
melittin from the bloodstream.
Another interesting project which may have direct relevance here was 
the construction of a molecularly imprinted polymer using p-cyclodextrin
as a functional monomer (Ng and Narayanaswamy, 2009). This 
represents a step toward natural compounds as recognition elements in 
an imprinted system, rather than merely conjugated to polymer 
supports.
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Figure 9: 0-cyclodextrin.
1.1.5 Peptides and Polymers
Several projects have made use of the conjugation of peptides with 
polymers, including an example in which phage display was used to 
obtain peptides that bound trinitrotoluene (TNT) that were then 
supported on a polymer scaffold and used to detect explosives in water 
(Cerruti et al., 2009). This system was able to differentiate between the 
target TNT and dinitrotoluene (DNT) yielding undetectable levels of 
binding to the latter.
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This is an interesting first step. However, in this system the polymer was 
present purely for support and to attach the peptide to the sensor grid. 
There was no imprinting action from the polymer, and no intention for it 
to take part in the binding process itself.
1.1.6 Current Applications
Of course, imprinted polymers can potentially find application wherever 
there is a need for reliable detection or perhaps even differentiation of 
one compound over another. However, current commercial applications 
are limited, although, there are many laboratory-scale examples of 
MIPs as chromatographic stationary phases (Ansell and Kuah, 2005, 
Boyd et al., 2007, Wistuba and Schurig, 2000, Liu et al., 2004) and 
sol id-phase extraction aids (Baggiani et al., 2007, Pereira and Rath, 
2009, Sharma et al., 2007).
MIPs as solid phase extraction materials are currently commercially
available, until recently only for a limited number of compounds, and
from a single manufacturer (SupelMIP® by Sigma-Aldrich). A greater
range of polymers is now available through Biotage (AFFINILUTE™) for
a wider range of compounds, yet still only as solid-phase extraction
materials. Although marketed applications appear somewhat limited, the
potential applications of imprinting science are put forward and eagerly
anticipated in several recent reviews on imphnted drug delivery systems
and therapeutic implications of imprinted polymer sensors (Cunliffe et
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al., 2005, Hillberg et al., 2005, Sellergren and Allender, 2005).
With regard to the potential use of MIPs in sensing, the 
electroconductive qualities of certain modem polymers may be worth 
some consideration. There are many examples in the literature of 
polymers which modulate their conductive properties in response to 
their immediate environment, whether it is changes in pH (Pei and Qian, 
1991), inorganic ions (Liu et al., 2001), or organic molecules (Shoji and 
Freund, 2002). A molecularly imprinted conducting polymer has been 
produced that was applied for detection of paracetamol binding to 
polypyrrole film (Ozcan and Sahin, 2007). Conducting polymers are 
reviewed further in (Lange et al., 2008).
1.2 Phage Display
Phage display, first conceived over 20 years ago (Smith, 1985), allows 
the selection of ligands which bind to a given target with very high 
affinity, often very rapidly. The use of a combinatorial library of, in this 
case, short peptides displayed on M13 bacteriophage allows for 
consecutive rounds of biopanning to be amplified easily in Escherichia 
coli allowing enrichment of binding clones over several rounds.
1.2.1 Surface Display
Small molecules can be expressed on a variety of cell surfaces, most
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utilised is the display of peptides or antibodies on the surface of a 
bacteriophage or "phage”. These expressed, or “displayed", molecules 
most commonly exist as simple peptides comprising as few as seven 
amino acid residues or larger proteins such as antibody fragments 
(Ascione et al., 2005). Other displayed molecules have included 
fragments of cDNA (Hufton et al., 1999), and even synthetic compounds 
(Woiwode et al., 2003). The common theme between these methods is 
the subsequent identification of the displayed moiety by sequencing the 
DNA of the displaying organism.
The phage display process requires a biopanning step during which the 
vast library of surface-displayed moieties, in the magnitude of 109 or up 
to 1011 different units, is allowed the opportunity to bind to an 
immobilized target. Any unbound phage are easily washed away along 
with any loosely bound particles, leaving only those phage displaying 
peptides which are tightly associated with the target. The tightly bound 
peptide-vectors can then be eluted with either a compound that is 
known to demonstrate greater affinity for the target molecule, or by non­
specific disruption of protein binding by, for example, lowering the pH 
with a glycine buffer.
After the selection of phage-peptide clones in the first biopanning round, 
those that show greater affinity for the target are then used in a further 
round of panning to enrich binding clones. After several rounds of
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panning, the harvested phage-peptide clones that display the highest 
binding are subject to DNA sequencing to elucidate the primary 
structure of the peptide which had been expressed on the surface 
(Azzazy and Highsmith, 2002).
1.2.2 The M13 Phage
The M13 is a filamentous bacteriophage, approximately 930nm in 
length and 6nm in diameter. If this was to be scaled up keeping the 
correct proportions, we would witness a structure the width of a pencil 
which is approximately four feet in length (Kehoe and Kay, 2005). The 
M13 bacteriophage lends itself well to the technology of phage-display 
for several reasons. Firstly, the single-stranded circular DNA has been 
sequenced in its entirety thus allowing substitution to predictably alter 
various phenotypic characteristics (van Wezenbeek et al., 1980). Also, 
the M13 phage is non-lytic, which therefore allows rapid and continuous 
amplification of the phage particles in host bacteria, whilst not depleting 
bacterial load, merely increasing generation time (Stegen and 
Hofechneider, 1970).
The main component of the phage structure is the genetic material,
which consists of 6,407 bases. This phagemid is encapsulated within a
shell composed of approximately 2,700 copies of the major coat protein
pVIII. One end of the phage is capped with five copies each of pVII and
pIX, while the other end contains five copies each of pill and pVI
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(Sidhu, 2001).
f  .2.3 Mechanism of Phage Infection and Replication
The minor coat protein plil is instrumental in the recognition and 
subsequent penetration of the host cell. The pill unit itself is divisible 
into three subsections: two N-terminus portions and one C-terminus 
portion. The C-terminus portion is anchored in the phage coat and has 
a roie in the assembly and ejection of the new phage particles at the 
membrane of the host cell. The first of the N-terminus regions is 
responsible for the recognition of the F-piius on the male E. coli cells, 
while the second is thought to mediate the withdrawal of the F-pilus into 
the periplasm, resulting in internalization of the phage genetic material 
(Kehoe and Kay, 2005).
Once the phage genetic material is internalized, the single-stranded 
DNA is converted into double-stranded DNA by bacterial enzymes and 
the synthesis of the phage proteins begins. The phage assembly 
commences as the proteins and ssDNA accumulate within the infected 
bacterium. The structural proteins (pVIII, pVII, pIX, pVI, and pill) are 
inserted into the inner bacterial membrane awaiting sufficient production 
of the phage genome.
Newly synthesized ssDNA - comprising the phage genome - is coated 
by pV to prevent its conversion to dsDNA, with the exception of a small
packaging signal which is left free of pV. This packaging signal is 
captured by a complex composed of the proteins pIV, pXI, and pi, which 
form an opening in the host cell membrane (Stassen et al., 1994). The 
phage particle is concurrently assembled and extruded from the 
bacterium at this complex, which is often described as a membrane 
pore (Yang et al., 2004). During construction, pV is removed from the 
ssDNA and the phage genome is coated with pVI11; five copies each of 
pVII and pIX are then placed at the end of the phage that contains the 
packaging signal.
In general, increases in supernatant phage in a culture of susceptible 
host bacteria are not seen until a period of 30-40 minutes has elapsed 
at 37°C. This would be the amount of time required for assembly of the 
new phage to begin. When host cell densities are very low it has been 
observed that a longer delay occurs before phage numbers increase. 
This has been referred to as a “replication threshold” (Wiggins and 
Alexander, 1985) or a “proliferation threshold” (Payne and Jansen, 
2002). Wiggins and Alexander report this density to be around 104 cells 
per millilitre for the phage-host combinations tested.
Bacteria are able to monitor their local population density through 
autoinducers or quorum factors that they secrete into the environment, 
thereby altering the expression of many genes and regulating the 
metabolic state of the sensing bacteria when concentrations are
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sufficient. Therefore, one explanation for the additional time required for 
phage replication to begin in lower population densities of host bacteria 
is that certain metabolic states are required for phage infection to occur 
(de Kievit and Iglewski, 2000).
The replication threshold density phenomenon can be extracted from a 
mathematical model (Schlesinger, 1932), which relies on the 
assumption that phage rely entirely on chance encounters with their 
hosts and that their ability to infect and reproduce in liquid culture can 
therefore be predicted by the equations that describe the movements 
and irreversible binding of inert particles under the influence of 
Brownian motion. This model states that:
where P/P0 is the fraction of phage that remains unbound at time t 
(minutes), C is the concentration of host cells per cubic centimetre 
(which remains constant at time Q, and k is an adsorption rate constant 
in cubic centimetres per minute that can be determined experimentally 
for a given phage-host system. This rate constant accounts for 
variations between systems including the number of binding sites per 
cell and the efficiency with which collisions actually result in infection. 
For example, the T4 phage can use several hundred binding sites per 
cell, whereas the M13 phage has only two or three binding sites per 
cell, so the k values for these two phages would be in the region of 2.4 
x 10'9 cm3min*1 (Stent, 1963) and 3 x 10‘11 cm3min'1 (Tzagoloff and
Pratt, 1964), respectively.
It follows from the equation above that if the concentration of host cells 
in culture (C) is lower, with all other parameters remaining equal, a 
larger proportion of phage will remain unbound at any given time (f). In 
a study which puts this equation under closer scrutiny (Kasman et al., 
2002), it was discovered that the host cell density itself determines the 
phage infection rate, irrespective of the presence of quorum factors. 
This was tested by comparing phage proliferation rates in known low 
populations of host bacteria and populations with the addition of media 
conditioned with quorum factors. Concentrating the same quantity of 
both phage and host bacteria into a smaller volume of the same media 
improved efficiency of infection three- to five-fold. The data presented 
suggested that phage infection can happen at any concentration of host 
cell providing there is sufficient presence of phage to ensure that 
contact is made and maintained.
1.2.4 Construction of a Phage Display Library
The majority of researchers who use phage display have very little to do
with the manufacture of the library. For the manufacture of the complete
library, a knowledge of the construction of DNA libraries is of greater
importance (Kehoe and Kay, 2005). A technique still in common use to
generate this effect is base substitution mutagenesis by terminal
transferase, first described by (Snow et al., 1987). The commercially
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available Ph.D-C7C M13 phage display library is a construction based 
upon random mutations of the gill gene, which codes for the surface 
protein pill.
Thomas Kunkel demonstrated in 1985 that single-base substitution 
mutations were possible to introduce into the lacZa gene in M13mp2 
(Kunkel, 1985). He was able to induce these mutations in a rapid 
procedure with 40-60% efficiency. Using two simple additional 
treatments of the DNA prior to transfection, it was possible to produce a 
site-specific mutation frequency approaching 100%. This high 
efficiency was obtained by using a DNA template containing several 
uracil residues in place of thymine. The template was found to have 
normal coding potential for the in vitro reactions typical of site-directed 
mutagenesis protocols, but was not biologically active upon transfection 
into wild-type E. coli cells. Therefore, expression of the desired change, 
present in the newly synthesised non-uracil-containing covalently 
closed circular complementary strand, was strongly favoured.
1.2.5 Utility of Phage Display
1.2.5.1 Protein Conformation
The technology of phage display has met many applications in recent 
years. In one study (Bai and Feng, 2004), proteins were selected that 
fold in only stable conformations. The authors suggest two basic
27
biophysical issues in protein design. One is to find mutations that make 
proteins thermodynamically more stable; the other is to find an amino 
acid sequence for a polypeptide chain that will fold to a target structure. 
They suggest that the second issue is more critical for testing the 
principles of protein folding.
To learn the factors that stabilise the proteins, researchers have 
become interested in studying the proteins from thermophilic 
organisms. These proteins are stable at very high temperatures. It is 
therefore hoped that the rules for stabilising proteins may be revealed 
after comparing the thermophilic proteins with mesophilic proteins. In 
this study (Bai and Feng, 2004), phage display and proteolysis were 
used to select stably folded proteins in which the DNA encoding the N- 
terminal half of the beta barrel domain (from cold shock protein CspA) 
was substituted with fragmented genomic E. coli DNA. The phage 
library was then challenged by several proteases. The authors isolated 
four proteins selected from library which were soluble and characterised 
them using NMR, CD spectroscopy and amide hydrogen exchange. 
The CD spectra indicated formation of the beta sheet structure 
consistent with the segment from the CspA.
1.2.5.2 Immunological Properties
Phage display libraries have also found their use in the selection of
internalising antibodies. In a study (Becerril et al., 1999), an antibody
library (scFv) based on the fd phage were exposed to SKBR3 cells
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(oestrogen receptor negative breast cancer cell line) which had reached 
50% confluency. The library was allowed contact for two hours, after 
which surface bound phage were removed. Cell membrane integrity 
was compromised using acetone, thus allowing the recovery of the 
internalised phage particles, which were subsequently detected using 
biotinylated anti-M13 immunoglobulins. The authors demonstrated for 
the first time that phage displaying an anti-receptor antibody can be 
specifically endocytosed by receptor expressing cells and can be 
recovered from the cytosol in infectious form.
Another example has been illustrated more recently (Casey et al., 
2004). In this case, the authors constructed a linear peptide display 
library of 20 amino acid residues fused to the N-terminus of pill of the 
M13 phage, which was exposed to the monoclonal antibody (MAb) for 
the apical membrane antigen-1 (AMA-1) -  one of the leading malaria 
vaccine candidates (Bueno et al., 2009, Epstein et al., 2007). Of the 
strongest binding peptides, none were found to have any sequences 
similar to the primary sequence of AMA-1; yet, binding of the peptide to 
the anti-AMA-1 antibody was disrupted by the addition of AMA-1 whilst 
none would bind to the isotype control MAb. Immunogenic studies in 
rabbits then showed that inoculation with the phage-derived peptides 
resulted in high titres of peptide-specific antibodies that were shown to 
be cross-reactive with recombinant AMA-1, indicating that the peptides 
behave as immunogenic mimics of the natural antigen.
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Another, perhaps more innovative, use of phage display has been 
demonstrated in a study which sought to bind one of the components of 
the toxin of the Thai cobra (Naja kaouthia). The toxin is a combination of 
agents: neurotoxin (paralytic) which acts upon nicotinic acetylcholine 
receptors, and cardiotoxic (cytolytic) acting upon cell membranes. The 
neurotoxic agents have been separated into four component parts (a, (3, 
y, and 6) (Cooper and Reich, 1972). Of these, a-cobratoxin constitutes 
the major component present in the venom. In this study (Byeon and 
Weisblum, 2004), the authors immobilised the a-cobratoxin to a micro- 
titre plate and carried out three rounds of panning against this target. 
The peptides of interest were chemically synthesised and used to 
create an “affinity resin” by their inclusion in an agarose gel, which was 
shown to then effectively deplete a-cobratoxin from crude venom.
1.2.5.3 Medicine
Phage display libraries have also been implicated for applications in
modern healthcare. Two recent reviews (Nilsson et al., 2000, Ruoslahti,
2000) have discussed the use of phage display technology in the
determination of peptides that target tumours and tumour vasculature.
The vascular endothelium varies throughout the body with respect to
the levels of various markers that are expressed (Pusztaszeri et al.,
2006). Tumour microvasculature represents an excellent target for
site-specific drug delivery as current anti-cancer treatments rely on
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toxicity to the rapidly proliferating tumour cells, although the high doses 
over long periods which are often required can be very debilitating as 
there is also significant toxicity to proliferating non-malignant cells. The 
concept of the “magic bullet” illustrates the desire to target the tumour 
itself, sparing healthy tissue from the damaging effects of the cytotoxic 
agent. To this end, many efforts have been made to specifically target 
the tumour vasculature, more recently using phage display as the 
technology of choice; an example of this being the selection of 
“antibodies to novel cancer-induced antigens expressed by tumours 
and by the tumour vasculature” (Mutuberria et al., 1999). As each type 
of blood vessel in the body displays endothelial markers that vary 
according to the type of tissue in which the vessel is found, a “magic 
bullet” could, in theory, be aimed specifically at any tissue.
Another imaginative application of phage display comes in the form of a 
potential vaccine to Human Immunodeficiency Virus (HIV). In a study 
(Zwick et al., 2003) involving antibody phage display, the point was 
made that one of the major frustrations in HIV vaccine development is 
the inability to form antibodies to the virus -  due to the very nature of 
the disease. In this study, the authors identified a novel antibody found 
to bind to a complex epitope on HIV-1 involving several of the key 
structures unique to HIV.
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1.2.5.4 Low Molecular Weight Compounds
1.2.5.4.1 Drugs
Few studies have attempted to obtain binding peptides to targets of the 
scale of low-molecular weight drugs. Studies published to date include 
phage display against dexamethasone (Yu et al., 2007) in which binding 
sequences were identified that matched albumin and a subunit of 
cytochrome c oxidase; methotrexate (Takakusagi et al., 2008) in which 
a binding sequence was identified that matched the drug’s target in the 
body (dihydrofolate reductase); and paracetamol (Smith et al., 2007) in 
which a peptide was isolated that bound preferentially to paracetamol 
over its structural isomers and was shown to reduce cellular toxicity in a 
hepatic cell culture model.
1.2.5.4.2 Texas Red
Several binding peptides were isolated from an M13 pill expressed 
phage display library that were found to modulate the spectral 
properties of target fluorophores (Rozinov and Nolan, 1998). Their work 
examined the interaction of the library, and subsequently the peptides, 
with Texas Red, Rhodamine Red, Oregon Green 514, and fluorescein.
After four rounds of biopanning with Ph.D-12 phage display peptide 
library a total of six clones were sequenced. Five of the clones shared a 
common sequence, designated TR401: KHVQYWTQMFYS. Initial 
binding studies used His6-tagged peptides bound to cobalt-containing
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beads producing beads which bound Texas Red very strongly, 
demonstrating a KD value of 1.6pM, although the binding affinity of the 
whole phage with the dye was very different, quoted as 0.27nM. On the 
whole, the peptide alone immobilised to beads is likely to provide the 
more accurate estimation of KD as the binding system itself does not 
alter during attempts to separate bound dye from unbound. This is in 
contrast to the whole phage system in which equilibrium is reached, and 
then polyethylene glycol (PEG) is added to precipitate the phage. This 
process was repeated for two further precipitations when dry phage 
pellets were then assessed for their Texas Red content. This 
modification of a system would disrupt the equilibrium as PEG changes 
the properties of the solution e.g. osmolarity, ligand concentration and 
solubility, thereby rendering subsequent KD determinations potentially 
inaccurate.
The remainder of this original paper and indeed the follow-up work 
(Marks et al., 2004) focuses upon the evolution of the peptides into 
progressively stronger binders. In fact, one of the “descendants” of 
TR401, designated TRS311, was quoted as having a KD of 0.09nM, 
although this was estimated using the phage precipitation method.
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1.3 Functional Plastibodies -  Aims and Objectives
Whilst the molecularly imprinted polymer is potentially of great value in 
any area where recognition or sequestration of a specific compound 
would be necessary, in reality, the binding specificity and affinity of the 
currently available MIPs would, in general, not meet the requirements 
for accurate and reliable sensing in critical areas of clinical or 
environmental science.
It is hypothesised that incorporation of a specific peptide, able to bind a 
specific ligand, into the imprinting process would allow for greater 
affinity and specificity in the interactions of ligand with the MIP, i.e. 
binding interactions with the MIP would involve ligand-imprinted peptide 
interactions.
Figure 10: Representation of the “Plastibody”. In this situation, a peptide which has been 
found to bind with high affinity and specificity to a template molecule is imprinted in its 
binding conformation, producing a robust, highly specialised binding site.
COOH
COOH COOH
COOH
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The principle aim of this project is to create such a peptide-conjugated 
molecularly imprinted polymer. The resulting material, whilst able to 
bind to its target with high affinity and specificity, should also be robust 
enough to withstand chemical or physical insult which would normally 
render a peptide or antibody system useless. Potentially, due to a 
restriction in the number of conformations the peptide is able to adopt, 
there may be a reduction in the energy required for the peptide to form 
a binding conformation making binding more favourable.
Specific objectives:
• To obtain a peptide capable of binding a low molecular weight 
compound with high affinity and specificity. Initial attempts were 
made to isolate such a peptide from a phage display library with 
propranolol as the biopanning target; although, when this proved 
unsuccessful, a peptide derived from phage display is described 
in the literature capable of binding the fluorophore Texas Red.
• Devise an assay protocol capable of thoroughly testing binding, 
both for the peptide in situ on the phage unit, and also 
immobilised to a solid support.
• Develop a polymerisation protocol that allows the undamaged 
peptide to retain a binding conformation such that it may rebind 
this target whilst retaining specificity and (possibly improving) 
affinity.
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Chapter 2
Phage Display against Propranolol
“Success consists o f going from failure to failure 
without loss of enthusiasm. ”
Sir Winston Churchill
2.1 Introduction
While phage display has met many applications in recent years, the 
majority focus on binding of the phage with large molecular structures, 
e.g. antibodies, proteins, or even cell surfaces. Comparatively few 
studies have been performed where the biopanning target is a small 
molecule, e.g. low molecular weight drug.
In this current work propranolol has been selected as the target of 
choice principally due to its wide use in imprinted polymer science 
(Kantarovich et al., 2009, Jantarat et al., 2008, Suedee et al., 2008, 
Reimhult et al., 2008), and particularly in the laboratory in which these 
studies were conducted (Castell et al., 2006). Propranolol is well 
characterised, comparatively safe, and somewhat inexpensive. Further, 
there are a number of other structurally similar molecules readily 
available to test the selectivity of ligand interactions. For these reasons,
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propranolol served as an ideal target.
The phage library used for these experiments was the Ph.D-C7C library 
available from New England Biolabs (MA, USA), which displayed on the 
N-terminus of the minor coat protein pill a random 7-mer peptide 
sequence flanked by cysteine residues, which spontaneously form a 
disulfide bridge, thus conferring some degree of secondary structure to 
the peptide sequence Figure 11.
Figure 11: Template phage displayed peptide structure from Ph.D-C7C Library.
Several biopanning strategies were employed which should result in a 
number of peptides with high affinity and specificity for propranolol 
(Figure 12), which can then be taken forward into the polymer 
conjugation and imprinting stage of the project.
HO
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Figure 12: Propranolol falls into the therapeutic category of antihypertensive. Its 
mechanism of action is through the blockade of beta-adrenergic receptors (beta blocker), 
thereby reducing sympathetic stimulation.
In order to force the selection of highly specific phage displayed 
peptides, it was considered necessary to include related compounds in 
the panning protocols. A “pre-screening” step was introduced in addition 
to the standard in-house phage display protocols making use of 
nabumetone (Figure 13), a compound which, whilst having a different 
pharmacological action to propranolol, shares certain structural aspects: 
the naphthyl group leading into the ether moiety resembles that of 
propranolol; also the ketone group on the aliphatic side-chain is 
approximately the same distance from the aromatic region as the 
hydroxyl group in propranolol. As nabumetone is only slightly soluble in 
water, pre-screening took place against the surface of precipitate.
Figure 13: Nabumetone is a non-selective non-steroidal anti-infiammatory drug (NSAID).
During exposure of propranolol to the phage library, compounds with far
38
greater water-solubility bearing the same aminopropanol-based side- 
chain were introduced, with the intention that any peptides with affinity 
only for this region of the molecule should be discarded with the initial 
washing steps. Only phage bearing peptides with affinity for the 
propranolol molecule as a whole should remain.
N
H
CH3 N
H
OHOH
Figure 14: Atenolol [A] and sotalol [B]. Both compounds fall into the therapeutic category
of "beta-blocker".
One “Round” of panning consisted of pre-screening against 
nabumetone, followed by four “sub-rounds” of exposure to propranolol 
in the presence of the competing compounds.
Once clones bearing peptides of interest were isolated from the phage 
library, it was necessary to measure the strength of the binding event.
A variety of approaches (Franz diffusion cell, filter centrifugation, a 
diffusion study in which the membrane was replaced with a biological 
layer (Madin-Derby canine kidney (MDCK-1) cells), and a
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microcentrifuge tube equilibrium dialysis system) were employed to 
determine the relative affinity of selected clones.
Specific objectives of this chapter were to isolate from the phage library 
a peptide with high binding affinity and specificity to the target molecule 
propranolol, and to develop methodology capable of assessing this 
binding.
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2.2 Materials and Methods
2.2.1 Media and Solutions
(Adapted from Pharmaceutical Cell Biology, Welsh School of Pharmacy, Cardiff
University Phage Display Protocol)
Unless otherwise stated, all reagents were obtained from Sigma- 
Aldrich, Gillingham, UK.
Agarose top: 20g/L of LB broth (Sigma L3022-1KG) in ddH20 +0.5mM 
CaCh +1g MgCl2.6 H2 0  +7g agarose. Autoclaved and stored solid at 
room temperature.
Blocking Buffer: 0.1M NaHCOa (pH 8 .6 ), 5mg/ml BSA, 0.02% NaN3. 
Filter sterilized and stored at 4°C.
TBS: 50mM Tris-HCI (pH 7.5), 150mM NaCI. Autoclaved and stored at 
room temperature.
PEG/NaCI: 20% (w/v) polyethylene glycol-8000, 2.5M NaCI. Autoclaved 
and stored at room temperature.
Iodide Buffer: 10mM Tris-HCI (pH 8.0), 1mM EDTA, 4M Nal. Stored at 
room temperature in the dark.
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SM Buffer: 5.8g NaCI, 2.0g MgSO4.7H20, 50ml 1M Tris-HCI (pH 7.5), 
5ml of 2% gelatin solution, H20  to 1L. Autoclaved and stored at room 
temperature.
Competing solution comprised 50pg atenolol (Sigma -  A7655-1G, BN# 
095K1644), 50pg sotalol (as hydrochloride, Sigma -  S-0278, BN# 
054K4074) per 1ml TBST. Competing solution was then stored in the 
dark in the fridge.
LB Medium: 20g/L of LB broth (Sigma -  L3022-1KG) in ddH20  with 
0.5mM CaCI2. (LB Broth is 10g Bacto-Tryptone, 5g yeast extract, 5g 
NaCI per litre.) Autoclaved and stored at room temperature.
LB/IPTG/Xaal Plates: 35g/L LB agar (Sigma -  L2897-1KG) in ddH20  
with 0.5mM CaCI2. (LB agar comprises 10g Bacto-Tryptone, 5g yeast 
extract.) Plates were stored in the dark at 4°C.
Propranolol was covalently attached to glass beads in-house by Dr. 
Jimmy Hedin-DahlstrOm using a method adapted from (Venter et al., 
1972).
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Figure 15: Reaction scheme for the coupling of propranolol to glass beads. Ref: J. Hedin- 
Dahlstrom (MRRU, WSP, Cardiff University) -  personal communication.
Propranolol free base: R<S-Propranolol hydrochloride (500mg, Acros 
Organics -  207320050, BN#A0201432) was dissolved in distilled water 
(500ml). Sodium Hydroxide solution (1M) was added dropwise and a 
white precipitate was formed. The resulting mixture was vacuum-filtered 
using a 0.45pm-pore Whatman cellulose acetate filter. The filtrate was 
washed with distilled water and freeze-dried for 24 hours. The free base 
was stored in the dark with desiccation at 4°C.
2.2.2 Phage Amplification Procedure
An overnight culture of E. coli was centrifuged at 10.400G at 4°C for 10 
minutes, the supernatant discarded and the pellet re-suspended in 20ml 
LB broth. A 3ml aliquot was placed into a sterile flask and diluted with
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LB broth (17ml), therefore producing culture in an early log phase. The 
phage eluate was then added to this allowing overnight contact time at 
37°C with vigorous shaking.
2.2.2.1 First Centrifugation Step
The culture was transferred to a centrifuge tube and spun at 10.400G at 
4°C for 10 minutes. The supernatant was transferred to a fresh 
centrifuge tube and re-spun. This should result in near complete 
removal of E. coli from the system. The upper 90% of the supernatant 
was transferred into a fresh tube with 1/6 volume of PEG/NaCI, allowing 
phage precipitation at 4°C for at least 60 minutes.
2.2.2.2 Second Centrifugation Step
This mixture was then centrifuged at 10.400G at 4°C for 15 minutes, the 
supernatant discarded, re-spun for 30 seconds and the residual 
supernatant removed with a micro-pipette. The phage pellet was re­
suspended in TBS (1ml), transferred to a micro-centrifuge tube and 
spun for 5 minutes at 4°C to pellet any residual bacterial cells. The 
supernatant was transferred to a fresh micro-centrifuge tube and re­
precipitated with 1/6 volume PEG/NaCI, incubating on ice for at least 15 
minutes.
This mixture was micro-centrifuged for 10 minutes at 4°C, the
supernatant discarded, re-spun for 30 seconds and residual 
supernatant removed with a micro-pipette. The phage pellet was re­
suspended in 200pl TBS with 0.02% NaN3. This was micro-centrifuged 
for one minute at 4°C to pellet any remaining insoluble matter and the 
supernatant transferred to a fresh tube and labelled as the amplified 
eluate.
2.2.3 Gene Sequencing of Identified Phage Clones
(Adapted from Pharmaceutical Cell Biology Welsh School of Pharmacy, Cardiff
University Phage Display Protocol)
Individual phage plaques were removed from an agar plate and 
transferred into LB broth (3ml) where they were maintained for two 
hours at room temperature to allow diffusion of phage particles from the 
agar. E. coli culture (30pl) was then added and the tubes were 
incubated at 37°C with shaking for four to five hours. Samples of the 
cultures (1.5ml) were then placed into microcentrifuge tubes for 
sequencing. The remaining culture was retained and diluted with an 
even volume of glycerol and stored at -80°C.
The samples for sequencing were precipitated using PEG/NaCI (200pl) 
at room temperature for 10 minutes, centrifuged at 14,500G for 10 
minutes and the supernatant discarded. The pellet was suspended in 
4M iodide buffer (100pl) then absolute ethanol (250pl) was added. The
resultant mixture was incubated at room temperature for 10 minutes to 
precipitate single-stranded DNA.
The samples were then centrifuged at 14.500G for 10 minutes and the 
supernatant discarded. The pellets were washed gently in 70% ethanol 
and dried briefly under vacuum. Molecular biology grade water (30pl) 
was added to each pellet and incubated at 65°C for 15 minutes before 
being transferred to 96 well plates for storage at -20°C.
The plated samples were processed at the Psychological Medicine 
department at the University Hospital of Wales, Heath Park on a 
Beckman Coulter Agencourt machine using the AMPure kit (Beckman 
Coulter Genomics, Buckinghamshire, UK).
2.2.4 Panning Against Propranolol
2.2.4.1 Panning Against Propranolol Free-Base as 
Suspension
Four centrifuge tubes were incubated with blocking buffer (50ml) for at 
least one hour at 4°C. Blocking buffer was then discarded and the 
tubes washed six times rapidly in TBST (TBS with 0.1% v/v Tween-20). 
The final wash of TBST was discarded and replaced with fresh TBST 
(2ml) and nabumetone (50mg, Sigma -  N6142-5G, BN#104K0801). 
Phage inoculate equivalent to 1x1011 plaque forming units (PFUs) was
46
then added, allowing contact time of one hour with orbital shaking at 
150rpm.
This mixture was centrifuged at 10.400G at 4°C for 20 minutes. The 
supernatant was placed in the next centrifuge tube with competing 
solution (1ml) and propranolol (50mg as free base), allowing contact 
time of one hour with orbital shaking at 150rpm. This mixture was 
centrifuged at 10.400G at 4°C for 30 minutes and the supernatant 
discarded. The propranolol sediment was washed three times with 
TBST, centrifuging each time for 30 minutes as above.
After removal of the final TBST wash, glycine buffer at pH2.2 (6ml) was 
used to dissolve the propranolol and to disrupt the peptide binding of 
the phage. After five minutes contact time, PEG/NaCI (1ml) was added, 
allowing at least one hour contact time at 4°C. This mixture was 
centrifuged at 10,400G at 4°C for 20 minutes and the supernatant 
discarded, re-spun briefly and residual supernatant removed with a 
micro-pipette. The phage pellet was then re-suspended in TBST (500pl) 
and placed in the next centrifuge tube with TBST (1.5ml), competing 
solution (1ml) and propranolol (50mg as free base) to commence next 
sub-round as above.
After the third sub-round, the phage pellet was suspended in TBS 
(200pl) ready for amplification in E. coli.
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2.2.4.2 Panning Against Propranolol Covalently Bound to 
Glass Beads
2.2.4.2.1 Standard Protocol
TBST (2ml) and glass beads functionalised with arylamines as shown in 
Figure 15 (10mg) were added to a pre-blocked centrifuge tube and 
phage inoculate added (2.2.4.1). After incubation for one hour at room 
temperature, this mixture was centrifuged at 10.400G at 4°C for 2 
minutes. The supernatant was placed in the next pre-blocked centrifuge 
tube with competing solution (1ml) and propranolol beads (10mg), 
allowing contact time of one hour with orbital shaking at 150rpm. This 
mixture was centrifuged at 10,400G at 4°C for 2 minutes and the 
supernatant discarded. The glass beads were washed six times with 
TBST. After the final wash with TBST was removed, the beads were 
washed with glycine buffer at pH 2.2 (1ml). After five minutes contact 
time, the supernatant was removed and neutralised with neutralising 
buffer at pH 9.1 (200pl). This step was repeated for a further two 
washes. PEG/NaCI (1ml) was added to each glycine wash, allowing at 
least one hour contact time at 4°C. This mixture was centrifuged at 
10.400G at 4°C for 20 minutes and the supernatant discarded, re-spun 
briefly and residual supernatant removed with a micro-pipette. The 
phage pellets were each re-suspended in TBS (200pl), and the third 
glycine wash was amplified in E. coli for the next round of panning.
An alternative experimental treatment was also devised in which phage 
were exposed to propranolol free base as insoluble complex, using the 
amplified eluate from the end of biopanning round one as input to an 
additional glass experiment, as summarised in Figure 16.
Phage
Library II
Propranolol
insoluble
complex
J U
- u
Propranolol 
Bound to 
Glass 
Beads
Output 1 2 3
Figure 16: The passage of phage from library to output through various biopanning
strategies.
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2.2A.2.2 Additional Protocol
When the protocols outlined in 2.2.4.2.1 did not appear to provide 
consensus binding clones, one additional biopanning protocol was 
developed in which the target remained propranolol covalently attached 
to glass beads, although biopanning was extended to five rounds, with 
the fourth and fifth rounds being treated with five glycine washes. All 
other details are as described in 2.2.4.2.1.
2.2.5 Determination of Binding Effect
2.2.5.1 Franz Diffusion Cell Assay
The basic design for this assay was adapted from Smith et al. 2007. 
Franz diffusion cells were used with Whatman 0.1pm track-etched 
polycarbonate membrane filters (Sigma, Z612405-100EA). DL- 
propranolol (3H) (Amersham Biosciences, TRK495)) was supplied with 
a specific activity of 29Ci/mmole. Phage clones expressing the peptide 
of interest and wild-type M13 were used for this study. Each treatment 
was incubated with 3H-DL-propranolol for one hour at room temperature 
prior to initiation of the study.
The donor chamber of the diffusion cell was inoculated with 1x1011 
phage units and 1x1012 3H-propranolol molecules (approx. 1.6pmoles), 
and the receiver chamber was sampled at time-points chosen to 
represent the initial rate of flux and the subsequent level of equilibrium
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(n=4).
This experiment was revisited several months later, with the same basic 
experimental setup but the replacement of the polycarbonate 
membrane with a Viskin dialysis membrane with molecular weight cut­
off of 12,000-14,000 Da.
2.2.5.2 Side-by-Side Franz Cell Study
Two base units from the Franz ceils were attached to each other such 
that both sides of the membrane could be stirred with magnetic stirrers 
(Figure 17).
One side of the system (the donor chamber) was loaded with 1.6nM 3H- 
propranolol solution prepared as described previously (2.6ml) and the 
other side (receiver) was loaded with phage suspension (2.6ml) 
containing 1x1012 PFU/ml. The donor chamber was sampled at various 
time-points to observe depletion of the 3H-propranolol. Sample volumes 
were replaced with TBS. The membrane employed was Viskin dialysis 
membrane with molecular weight cut-off of 12,000-14,000 Da.
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Figure 17: "Side-by-side" Franz cell setup.
2.2 .5 .3  MDCK-1 Transport Study
Madin-Derby canine kidney (MDCK) cells were cultured to 70-80% 
confluence in DMEM-F12 containing 10% heat inactivated foetal bovine 
serum. Cells were seeded at a density of 4 x 105 cells.cm'2 onto 
Transwell® Clear culture inserts (6.5mm diameter, 0.4|jm pore polyester 
membrane, Corning, Sigma Aldrich, Gillingham, UK) allowing five days 
in vitro time (IVT) for the formation of a confluent monolayer with well 
developed tight junctions. Transepithelial electrical resistance (TER) 
was measured using an endohm (World Precision Instruments, Florida, 
USA) daily from 48 hours IVT to ensure adequate barrier function of the 
monolayer.
In addition to 3H-propranolol as the substance under test (which diffuses
transcellularly), 14C-mannitol (Sigma, 53mCi/mmol), a paracellular
marker, was also employed thus monitoring the continued quality of the
52
intercellular tight-junctions.
Phage inoculation (1x1011 PFUs, either biopanning-enriched clone or 
wild-type M13) was allowed one hour to equilibrate with 3H-propranolol 
and 14C-mannitol in TBS. This mixture (200pl) was placed in the apical 
chamber of the Transwell© insert, with serum-free media (Dulbecco’s 
Modified Eagle’s Medium (DMEM), Invitrogen, 42430-025.) in the 
basolateral chamber. Samples of 200pl were taken from the basolateral 
chamber at each time-point (0, 5, 10, 15, 20, 30, 40, 50, 60, 75, and 90 
minutes) and the volume replaced with fresh DMEM. Each sample was 
placed in a scintillation tube to which was added Optiphase-Hisafe 3 
(3ml, PerkingElmer, MA, USA), the radioactivity was then measured 
using dual-channel counting on a Tri-Carb 2900TR Liquid Scintillation 
Analyzer (Wolf Laboratories Ltd., Pocklington, UK).
2.2.5.4 Filter Centrifugation
A phage suspension was prepared in TBS to give 1x1011PFUs per ml. 
Phage suspension was allowed one hour to equilibrate with a 1:1 molar 
solution of 3H-propranolol. The equilibrated mixture (500pl) was loaded 
into a Microcon centrifuge filter and spun at 500G for 30 minutes. The 
filtrate was then counted using Liquid Scintillation.
2.2.5.5 Propranolol Affinity for Experimental Materials
Experimental stock 3H-propranolol was diluted to 0.4nM (1ml) and
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placed in glass sample tubes. The materials were each added to the 
tubes and allowed to equilibrate for 24 hours at 37°C. Samples (200pl) 
were then taken from the solution to ascertain depletion of 3H- 
propranolol. The samples were measured using Liquid Scintillation.
2.2.5.6 Microcentrifuge Tube Equilibrium Dialysis
The basic design for this study comes from (Reinard and Jacobsen, 
1989). Briefly, the lid was cut from a microcentrifuge tube, inverted and 
filled with a pre-equilibrated 1:1 stoichiometric ratio of 3H-propranolol 
and phage clones of interest or control (260pl mixture). Basic setup is 
illustrated in Figure 18: Basic microcentrifuge dialysis setup.
Microcentrifuge tube
Receiving phase
Viskin dialysis membrane
Donor phase
Figure 18: Basic microcentrifuge dialysis setup.
A section of Viskin dialysis membrane (MWCO: 12-14,000 Da) was 
placed over the lid and the body of the microcentrifuge tube was then 
replaced. Using a hypodermic needle, a small hole was made in the 
body of the tube through which was injected 260pl TBS. This dialysis
unit was then wrapped in parafilm and incubated at 37°C with orbital 
shaking at 100rpm for 24 hours. Experiments were performed in 
quadruplicate and the assay was verified by the inclusion of a positive 
control consisting of 3H-propranolol and slices of polycarbonate 
membrane in the donor chamber.
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2.3 Results and Discussion
2.3.1 Panning Against Propranolol
The phage populations at each stage in the panning were as should be 
expected, bearing in mind that the weakest binders and non-binders are 
removed before the glycine elutions in the washes with TBST. Each 
elution with glycine buffer then removes phage with progressively 
stronger binding affinities from the target. By the third glycine wash, 
only those with the greatest affinity should remain. However, in 
standard phage display protocol, the target would normally be washed 
six times with TBST. Whilst this was possible with the experiment that 
involved panning against propranolol covalently bound to glass beads, it 
was impractical to do this when panning against propranolol free-base 
as an insoluble complex. The reason for this is that each wash with 
TBST required centrifugation to re-sediment the base to allow removal 
of the supernatant, and even this was not always as efficient as would 
be expected as the propranolol had a tendency to readily resuspend at 
the slightest agitation.
Typical results are shown in Figure 19 demonstrating the relative 
numbers of phage recovered at each stage in the panning process.
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Figure 19: Number of plaque forming units recovered from each elution with glycine 
buffer pH 2.2 over three rounds of panning against propranolol free base as precipitate.
At the end of round one, only the third glycine elution was amplified for 
inclusion in the second round. This accounts for the decrease in 
numbers of phage present in the first glycine elution of round 2 and the 
increase observed in the third elution of round 2, which contained the 
enriched highest affinity binders.
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Table 1: Peptides derived from phage display against propranolol. Table shows peptide 
sequence along with in which output number(s) the peptide was present (outputs defined 
in Figure 16) and the % of that peptide in the whole sequenced sample from the free base 
and glass experiments. Full structures are shown in Appendix 1.
Peptide
Sequence
Output Free Base Glass
EMTSTRA 1,2 14.4 8.0
NANNRLY 1 4.1 Nil
PAQDPRY 1,2 1.0 4.0
QIKHRHM 1,2 4.1 4.0
No consensus binding sequences were observed in output 3, however 
a single clone was observed with the sequence EPRATST, which 
shares certain structural similarities with the sequence EMTSTRA found 
in outputs 1 and 2. On the whole, based on this data alone, EMTSTRA 
would seem to be the most promising peptide to take forward into the 
binding assessments, as it was present in the phage panning 
procedures against propranolol free base, and was enriched when free 
base-exposed phage were then exposed to propranolol-functionalised 
glass beads. EMTSTRA was present in the highest proportion in both 
free-base and glass experiments.
2.3.2 Demonstration of Binding
2.3.2.1 Franz Diffusion Cell Assay
During these experiments, a peptide-phage clone was incubated with 
the ligand, propranolol, in the apical chamber. If an interaction occurred
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between peptide and propranolol the expectation was that a reduced 
amount of propranolol would be free for diffusion from the apical 
chamber across the semi-permeable membrane to the basal chamber. 
Sampling the receiving chamber in the diffusion cell system affords 
calculation of a rate of accumulation of propranolol. This rate of 
accumulation should be lower as the phage present in the donor 
chamber bind to the propranolol.
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Amount of 3H-propranolol diffused: 
Phage (NANNRLY)
Phage clone (NANNRLY) 
Wild-type M13 
No phage control
Time (minutes)
Amount of 3H-propranolol diffused: 
Phage (QIKHRHM)
b  0.6-
«  0.2
Phage clone (QIKHRHM) 
- m -  Wild-type M13 
- a -  No phage control
500 1000 1500
Time (minutes)
2000
Figure 20: Franz cell diffusion pattern of 3H-propranolol through polycarbonate
membrane (n=4±SD).
Figure 20 shows the diffusion of propranolol across polycarbonate 
membrane. In each case, a significant difference (p<0.05) was found
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between the phage clone and the non-phage control. However, the 
difference is contrary to hypothesis, suggesting that the presence of the 
phage is somehow facilitating the diffusion of propranolol across the 
membrane. At the time, no logical reason could be proposed for this 
effect; therefore different binding assessment methodologies were 
employed.
When the Franz cell system was revisited several months later with a 
more thorough understanding of the materials involved, the 
polycarbonate membrane was replaced with Viskin dialysis membrane, 
thus greatly reducing the amount of propranolol lost in non-specific 
binding to experimental materials.
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Figure 21: Franz cell diffusion pattern of 3H-propranolol through viskin dialysis
membrane (ns4±SD).
Figure 21 shows the diffusion of propranolol across viskin dialysis
membrane. Whilst there is the unusual effect of all phage treatments
visually appearing to have enhanced propranolol transmission
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compared to control, no statistically significant difference is found when 
comparing any of the treatments to control using one-way ANOVA and 
Dunnett’s multiple comparison test.
This unusual diffusion pattern may have been, in part, related to the fact 
that only the receiving chamber was stirred in the conventional Franz 
cell setup. This could allow a layer of phage particles to build up on the 
donor side of the membrane, which may, in turn, affect propranolol 
diffusion. Therefore, the new “side-by-side” method was devised in 
which two Franz cell bases (with sampling arms) were clamped 
together to allow stirring of the phases on each side of the partition 
membrane (Section 2.1).
2.3.2.2 Side-by-Side Franz Cell Study
In this study, 3H-propranolol was placed on one side of the membrane 
and phage inoculum was placed on the other. Therefore, the 
observation is of depletion of propranolol from the donor chamber over 
time.
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Figure 22: Diffusion of 3H-propranolol from the donor chamber of a side-by-side Franz
cell setup (n=41SD).
This experiment still showed no significant difference (p>0.05) in the 
amount of propranolol diffused whether the receiving chamber 
contained phage clone, insert-less wild type M13, or control (blank 
TBS).
An interesting observation was made during the course of this 
experiment: the level of the liquid in the sampling arms either side of the 
membrane were equalised before the experiment began, yet, by the 
end of the experiment the level was consistently higher in the sampling 
arms that contained phage -  whether library clone or wild type. This 
would suggest that the phage exert another force upon the system, 
possibly through an osmotic effect. The level of this osmotic effect 
would probably be irrelevant at higher concentrations of propranolol but
where the concentrations were in the nanomolar range it may have 
been sufficient to give rise to the observed phenomenon.
2.3.2.3 MDCK-1 Transport Study
I
i
i
100
I
Control
Wild Type Ml 3 
EMTSTRA
Figure 23: Total amount of 3H-propranolol diffused into receiving chamber when exposed 
to phage expressing the sequence EMTSTRA (n=4±SD).
As apparent from Figure 23, equilibrium was not reached over the 
course of the 90 minutes of sampling. The unusual artefact observed in 
the Franz cell experiment is also observed here, in that the greatest 
levels of flux appear to be associated with treatments containing phage.
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Figure 25: Total amount of 3H-propranolol diffused into receiving chamber when exposed 
to phage expressing the sequence PAQDPRY (n=4±SD).
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Figure 24 shows only the first four time points from Figure 23.
♦  Control
*  Wild Type Ml 3 
-*• EMTSTRA
Time (mutes)
Figure 24: Total amount of 3H-propranolol diffused into receiving chamber when exposed 
to phage expressing the sequence EMTSTRA (n-4±SD). First four points only.
These data suggest that in the initial phase of propranolol transport 
through the MDCK-1 cells, there is no significant difference between 
wild-type phage, phage clone or control.
Figure 25 and Figure 26 show a repeat of the MDCK cell transport 
studies using a phage clone with a different peptide insert (PAQDPRY).
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Figure 26: Total amount of 3H-propranolol diffused into receiving chamber when exposed 
to phage expressing the sequence PAQDPRY (n=4±SD). First four points only.
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As in the previous experiment, there is no significant difference (p>0.05) 
between treatments in the transport of propranolol.
Control
Wild Type M13
PAQDPRY
1*
100
Figure 27: Total amount of 13C-mannitol diffused into receiving chamber when exposed 
to phage expressing the sequence PAQDPRY; mean and standard deviation shown
(n=4±SD).
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Whilst the permeability of the monolayer to mannitol appeared greater 
in the control group, which suggests that the presence of phage has 
affected the transmission of mannitol from the apical to the basolateral 
chamber, the difference is in fact not considered to be statistically 
significant (p>0.05).
Two further controls were carried out, but this time without the MDCK-1 
cell layer. Thus, 3H-propranolol was passed across the Transwell© 
insert alone (Figure 28).
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Figure 28: Amount of 3H-propranolol diffused across the Transwell© polycarbonate 
insert without the presence of MDCK cells.
With no cells to provide a barrier function, it was assumed that
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equilibrium would be reached within a few minutes, although, as is 
evident from Figure 28, equilibrium had not yet been reached after two 
hours incubation. An important observation at this stage relates to the 
materials test shown later in Figure 31. The inserts in the Transwell© 
system are manufactured from polycarbonate, which was shown to bind 
a significant amount of propranolol (Section 2.3.2.5). The rate at which 
equilibrium is reached may be affected by this extra binding event.
2.3.2.4 Filter Centrifugation
In the first experiment, a 1:1 ratio of phage to 3H-propranolol molecules 
was allowed to equilibrate, and then dosed into a Microcon 
microcentrifuge filter. Figure 29 shows the amount of propranolol that 
passed through the filter under each treatment.
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Figure 29: Propranolol (DPM) liberated by filter under each treatment (n=4±SD).
Much of the propranolol has been lost during this experiment; the initial
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dose for each compartment was 26,000 DPM, although it is clear that 
the presence of the phage is causing an increase in the amount of 
propranolol passing through the filter under centrifugation. This is 
irrespective of whether the phage carries a peptide insert or is wild-type 
M13.
The experiment was repeated with one clone, increasing the ratio of 
phage to propranolol to 4:1. Figure 30 shows the results with the 
EMTSTRA clone clearly affording increased filtration of propranolol 
against control.
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Figure 30: 3H-propranolol liberated via centrifuge filter. Four-fold excess of propranolol
to phage was used (n=4±SD).
The filters in the microcentrifuge tubes used for the “filter centrifugation” 
experiments are regenerated cellulose with 100kDa molecular weight 
exclusion. The insert containing the filter is made of polycarbonate. 
Propranolol was shown (Figure 31) to bind extensively to polycarbonate
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remove varying amounts of propranolol from solution: Diaflow removes 
only 0.40% of propranolol, Cellulose Nitrate removes 87.3%, 
Polycarbonate removes 40.98%, MSI removes 52.06%, Polypropylene 
removes 6.33%, Whatman filter paper #1 removes 34.58%, and 
Whatman filter paper #54 removes 41.22%.
After carrying out the above experiment, a further material was 
considered: Viskin dialysis membrane, shown in Figure 32.
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Figure 32: Depletion of 3H-propranolol from solution after 60 minutes incubation with
Viskin dialysis membrane.
Although this experiment was carried out at a far higher concentration 
of propranolol than is used in the binding assays, it provided enough 
encouragement to continue with this membrane, as 88.1% of the 
propranolol remained free. This membrane was then used to perform 
the revisited Franz cell studies described in sections 2.2.5.1 and 
2.3.2.1.
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at low concentrations. It is apparent from the combined data that the 
phage compromise the filters in the microcentrifuge tubes, thus allowing 
a greater permeation of propranolol.
In short, most of the propranolol is removed from the system by non­
specific binding with experimental components (membranes, membrane 
inserts), while the presence of phage in the system appears to increase 
the amount of propranolol passing through the filter. There is no 
evidence of selectivity, as the wild-type M13 provided the same effect 
as the biopanning-enriched clones.
2.3.2.5 Propranolol Affinity for Experimental Materials
Figure 31: Percentage of the original 3H-propranolol dose recovered from solution after 
60 minutes incubation with various materials.
After incubation with propranolol, the various materials were seen to
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2.3.2.6 M icrocentrifuge Tube Equilibrium  Dialysis
I  Donor I  Receiver 3  Membrane
EMTSTRA PAQOPRY QIKHRHM NANNRLY Wild Type PC Membrane Blank
Figure 33: Diffusion of 3H-propranolol molecules in the presence of 1:1 ratio of phage
particles, n=4±SD.
PAQDPRY PC MembraneEMTSTRA QIKHRHM
Figure 34: Proportion of 3H-propranolol found in the phage-containing chamber after 24 
hours (1:1 ratio of phage particles to propranolol molecules). Polycarbonate membrane 
is included to demonstrate the effect of binding propranolol, n=4±SD.
These data clearly show no difference in the proportion of propranolol
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free to diffuse to the receiving chamber between any of the phage 
treatments, which suggests that none of the four phage clones exhibit 
any binding effect. The treatment with polycarbonate membrane, which 
has previously been shown to bind propranolol, was found to have a 
statistically significant difference from blank (p<0.05).
After the modified biopanning procedure described in Section 2.2.4.2.2, 
12 further clones were examined using the same microcentrifuge tube 
dialysis method, shown in Figure 35.
0.5 -
Figure 35: Twelve further clones examined using the microcentrifuge tube dialysis 
method using viskin dialysis membrane, (n=4±SD).
None of these clones have shown any significant difference in the 
diffusion pattern of 3H-propranolol in any of the methods attempted, 
suggesting that the specific binding of phage clones to propranolol was
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very limited. An important observation was that propranolol was shown 
to bind non-specifically to a range of materials. Therefore it is possible 
that further non-specific interactions, between propranolol and other 
phage components, may have been responsible for the absence of 
target selectivity.
2.4 Further Discussion
The construction of the experiment should have provided binding 
peptides with high affinity (due to the use of three to five glycine 
washes), and high specificity (due to the use of a pre-screening step 
with nabumetone and the presence of competing structurally related 
compounds).
As propranolol is only slightly soluble in water, the vast majority of the 
base will remain as an insoluble complex. However, as with most 
systems, equilibrium will exist in which some portion of the propranolol, 
however small, is always in solution. A limitation of panning against 
propranolol as an insoluble complex is the possibility that the peptides 
derived from this method bind more strongly to the surface presented 
by the insoluble propranolol complex as compared to individual 
propranolol molecules in solution. It is possible that some phage that 
displayed peptides that bound to propranolol in solution may have been 
excluded from further rounds of panning during the washes with TBST.
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Fundamentally, the concept of phage display against low-molecular- 
weight compounds is sound, when due consideration is given for the 
properties of that compound. However, in hindsight, propranolol was a 
poor choice for target molecule due to the large hydrophobic region 
which partly is responsible for the high levels of non-specific binding 
observed in the materials test (section 2.3.2.5).
The principle aim of this chapter was to isolate from the PhD-C7C 
Phage Display Library a novel peptide capable of binding propranolol 
with high affinity and specificity. Several biopanning protocols were 
employed, and whilst some peptide-phage clones were enriched, no 
binding effect was observed despite use of multiple binding assay 
methodologies.
An important consideration is the choice of biopanning target. In this 
instance, a racaemic mixture of R/S-propranolol was used, which, when 
combined with the low molecular weight and few functional groups, may 
have contributed to the inability to isolate binding clones.
With the understanding that a target molecule is chosen diligently, 
phage display is a powerful tool for the isolation of high quality binding 
peptides. A good target molecule should have several functional groups, 
providing a unique “fingerprint” when exposed to the phage peptide. It
should also exhibit only a low level of non-specific binding to, for 
example, the plasma protein albumin. When considering drug 
molecules, warfarin (which is ~99% albumin-bound in the blood (Chan 
et al., 1994)) would be a poor choice, whereas sotalol (which is not 
albumin-bound (Carr et al., 1992)) would be far less likely to bind non- 
specifically to phage components or experimental materials.
2.5 Conclusions
In conclusion, whilst phage display has shown some success in the 
search for binding ligands to some low molecular weight drugs, namely 
paracetamol, dexamethasone, and more recently methotrexate, such a 
process may not be suitable for all small molecules. Work in 
subsequent chapters focuses on a peptide identified previously, aiming 
to tackle the challenges encountered upon the incorporation of the 
binding peptide into the polymer scaffold whilst retaining a conformation 
that favours binding.
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Chapter 3
Texas Red and the binding peptide: 
TR401
“A wise man will make more opportunities than he finds. ”
Francis Bacon
3.1 Introduction
Sulforhodamine 101 acid chloride (Texas Red, Mw: 625), is widely used 
as a fluorescent agent to stain cell specimens and in other applications 
including fluorescent-activated cell sorting, immunohistochemistry, and 
fluorescence microscopy (Titus et al., 1982, Park et al., 2010, Lanier 
and Loken, 1984, Richardson et al., 2008). The acid chloride group on 
Texas Red provides the reactivity required to link the probe to amines or 
alcohols. As the free acid has essentially the same physicochemical 
properties as the acid chloride, and conjugation was not required, it was 
used throughout in these studies.
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aFigure 36: Sulforhodamine 101 acid chloride (Texas Red) (A), and sulforhodamine 101
(B).
The first stage in this assessment was to carefully establish the 
excitation and emission maxima for sulforhodamine 101 (SR) and 
determine whether the available filters for the BMG Labtech FLUOstar 
OPTIMA plate-reader used in earlier experiments were appropriate; 
then to construct calibration curves to assure linearity of the fluorescent 
response. A thorough investigation of the fluorescent properties of SR is 
presented in Appendix 2.
For the purposes of this study the peptide identified by Rozinov and 
Nolan (described in Chapter 1, section 1.2.5.4.2) (Rozinov and Nolan, 
1998) TR401, was used with a minor modification (although, for ease of 
description, this modified peptide is still referred to as TR401): the C- 
terminus of the original peptide now hosts a glycine-glycine-glycine 
spacer followed by a terminal cysteine residue (Figure 37).
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Figure 37: Structure
of TR401 (KHVQYWTQMFYS) with the addition of three glycine 
onfcysteine residues to the C-temnnus.
This provided specific functionality through which the peptide could be 
conjugated to solid supports. The N-terminus hosts the only two primary 
amines in the peptide while the C-terminal cysteine residue provided a 
unique sulfhydryl group.
After several failed attempts to demonstrate binding when TR401 was 
covalently attached to glass surfaces (Appendix 3), Merrifield Resin was 
chosen as a solid support for the attachment of the peptide via the C- 
terminal sulfhydryl group.
Merrifield Resin is a chloromethylated copolymer of styrene and 
divinylbenzene. Robert Bruce Merrifield developed the material 
(Merrifield, 1963) which he first described as an alternative approach to 
peptide synthesis.
Figure 38: Merrifield Resin.
The methylchloride may be modified in several ways to add functionality 
to the resin to which a peptide may be attached, and subsequently, 
polymerisation may be established.
Sulfosuccinimidyl 4-[A/-maleimidomethyl]cyclohexane-1-carboxylate
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(Sulfo-SMCC, Figure 39) has been used extensively as a linking group 
in projects such as synthesis of dendrimer-antibody conjugates 
(Thomas et al., 2004) and peptide modification of surfaces for guided 
cell adhesion (Yu and Shoichet, 2005).
Na +
NO.
Figure 39: Sulfosuccinimidyl-4-[N]maleimidomethyl] cyclohexane-1-carboxylate (Sulfo-
SMCC).
N-Hydroxysuccinimide (NHS) esters react with primary amines at pH 7- 
9 to form stable amide bonds. Maleimides react with sulfhydryl groups 
at pH 6.5-7.5 to form stable thioether bonds.
Before it was possible to proceed with the molecular imprinting aspect 
of the project, it was necessary to obtain a thorough understanding of 
the binding properties of the peptide, and also its limitations. With this in 
mind, the experiments in this section assessed Bmax and KD for the 
SR-TR401 interaction in a range of solvents, and also the specificity of 
TR401 for SR.
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The naphthyl group of naphthyl ethylenediamine (NED) Figure 40 
exhibits a fluorescence spectrum that may shift if the primary amine 
reacts to form a stable amide bond (Sturgeon and Schulman, 1975).
The first assay in this set assessed the binding of SR to TR401 in 
distilled water. In the second assay, water was replaced with TBS (pH 
7.5) in order to assess the effect of pH or buffering capacity on binding. 
The third assay was intended to explore TR401 affinity for SR in 
ethanol, anticipating the use of ethanol in subsequent imprinting 
strategies. The fourth, fifth and sixth assays in this section looked at the 
specificity of TR401 for SR by challenging the peptide with the potential 
cross-reactants fluorescein, rhodamine 123, and rhodamine 6G (Figure
Figure 40: Naphthyl ethylenediamine (NED).
41).
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Figure 41: Rhodamine 6G (A), rhodamine 123 (B), and fluorescein (C).
The principle aim of this section of work was to develop a reliable and 
robust assay that would give consistent values for KD and fully test the 
binding properties of TR401.
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3.2 Materials and Methods
3.2.1 Linking chemistry
3.2.1.1 Solution Chemistry -  1
Solutions of (3-aminopropyl)triethoxysilane (APTES) or (3- 
mercaptopropyl)triethoxysilane (MPTES) (both Sigma-Aldrich, 
Gillingham, UK, catalogue numbers A3648-100ML and 63797-25ML-F, 
respectively) (1%) in ddh^O were incubated with Sulfo-SMCC (Sigma, 
M6035, Schnelldorf, Germany) in saline buffered to pH 7 at room 
temperature for one hour with vigorous stirring.
The solutions were then treated with ninhydrin (Figure 43) (1% in 
acetone) or Ellman's reagent (Figure 44) (2mM in 50mM sodium 
acetate aqueous solution), respectively, and colour changes observed.
Figure 42: APTES (A) and MPTES (B).
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Figure 43: Ninhydrin (2,2-Dihydroxyindane-1,3-dione).
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Figure 44: Eilman's reagent, (5,5'-dithiobis-(2-nitrobenzoic acid))
3.2.1.2 Solution Chemistry -  2
Naphthyl ethylenediamine (NED) was conjugated in solution to Sulfo- 
SMCC to confirm the effect demonstrated using the ninhydrin reaction 
described in 3.2.1.1.
A 1:1 molar ratio of NED and Sulfo-SMCC was dissolved in water (1pM) 
and incubated at room temperature for two hours with stirring. 
Excitation and emission fluorescence scans were performed prior to 
addition of the Sulfo-SMCC and at completion of the reaction.
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Figure 45: Conjugated product of NED with Sulfo-SMCC.
This experiment relied upon the fluorescence spectrum of the product 
(Figure 45) shifting from that of untreated NED by a sufficient margin to 
be detectable.
3.2.1.3 Peptide attachment to Merrifield Resin
Merrifield Resin (MR) (200-400 mesh, 1% cross-linked with DVB, 1.8- 
2.0 mmol Cl/g, Acros Organics -  349160500, BN#A0249177) was 
functionalised to express primary amines via azide reduction 
(performed in-house by J. Bowen). Briefly, MR was reacted with sodium 
azide in DMF at 70°C for 24 hours, followed by treatment with triflic acid 
in dichloromethane at 0°C for one hour. The amine-functionalised MR 
was suspended in distilled water at 10mg/ml, of which 0.5ml was added 
dropwise to a solution of Sulfo-SMCC (2ml of 1 mg/ml). This was 
maintained at room temperature with stirring for one hour. The resin 
was then centrifuged at 10.400G for 5 minutes and the supernatant 
removed. The resin was then washed twice in distilled water (2ml) to 
remove any unreacted Sulfo-SMCC.
The resin was re-suspended in 0.5ml distilled water, of which 100pl was
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added slowly to 2ml TR401 solution in distilled water (0.5mg/ml). This 
was maintained at room temperature with stirring for one hour, washed 
twice with 2ml of distilled water, and then re-suspended in 1ml distilled 
water. Functionalised resins were stored at 4°C and used within 48 
hours.
A solution of TR401 was prepared in distilled water for which a UV 
absorption scan was acquired. This solution was then used in the 
linking reaction with functionalised Merrifield Resin, and the reaction 
mixture scanned again. It was assumed that the difference between the 
two readings illustrates a loss of peptide from solution to the resin.
3.2.2 Development of Binding Assay Protocol
3.2.2.1 Calibration using polypropylene plates
Standard solutions of SR in distilled water were prepared ranging from 
100nM to 4000nM. Aliquots (200pl) were then placed into a black 
polypropylene 96-well plate (Nunc, Thermo Scientific) and read using a 
FLUOstar OPTIMA (BMG Labtech, Offenburg, Germany) (Ex 544nm; 
Em 590nm). Two replicates of each concentration were examined.
3.2.2.2 Excitation and emission scans of sulforhodamine 
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A solution of SR (150nM) was prepared in distilled water and scanned
using an Aminco-Bowman Luminescence Spectrometer (Thermo
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Spectronic, Madison, Wl). An excitation scan from 450nm to 590nm 
was performed, measuring the intensity of fluorescence emitted at 
603nm. An emission scan from 560nm to 700nm was performed using 
an excitation wavelength of 544nm (gain=750V).
3.2.2.3 Fluorescence Titration
Solutions were prepared of SR (0.2mM) and TR401 (0.2mM). The SR 
solution was mixed with distilled water in equal parts and this was used 
as the starting solution (now 0.1 mM). The TR401 solution was mixed 
with the initial SR solution in equal parts and this was used as the 
titration solution (now 0.1 mM SR and 0.1 mM TR401).
Amounts and concentrations of each compound are shown in Table 2 
including monomer-to-template (M/T) ratio, which allows an indication of 
the number of peptide molecules present for each molecule of SR.
Emission intensities at each addition were observed using the 
Luminescence Spectrometer using excitation and emission 
wavelengths of 585nm and 603nm, respectively (gain=1020V).
91
Table 2: Volumes added and resultant monomer: template ratio of titration experiment
with SR and TR401.
Addition
(M>)
Total vol 
(Ml)
[SR] pM
[TR401]
pM
M/T ratio
1 0 500 0.1 0 0
2 0.5 500.5 0.1 0.100 1.00
3 0.5 501 0.1 0.200 2.00
4 0.5 501.5 0.1 0.299 2.99
5 0.5 502 0.1 0.398 3.98
6 1 503 0.1 0.596 5.96
7 1 504 0.1 0.794 7.94
8 1 505 0.1 0.990 9.90
9 2 507 0.1 1.381 13.81
10 2 509 0.1 1.768 17.68
11 3 512 0.1 2.344 23.44
12 5 517 0.1 3.288 32.88
13 10 527 0.1 5.123 51.23
14 20 547 0.1 8.592 85.92
15 30 577 0.1 13.345 133.45
16 40 617 0.1 18.963 189.63
17 50 667 0.1 25.037 250.37
3.2.2.4 Merrifield Resin Titration
A solution of SR in water (10nM) was placed in a microcentrifuge tube, 
to which resin was added gradually in small increments. The resin was
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present in a suspension of Ipg/pl in water. Cumulative amounts added 
were 0, 1,3, 5, 10,15, 20, and 25pg. Treatments used were “No Resin”, 
“Untreated Resin”, “Amine-functionalised Resin”, “Sulfo-SMCC- 
functionalised Resin”, and “TR401-functionalised Resin”; n=4. Tubes 
were spun at 10,400G for five minutes, and then the supernatant was 
scanned at excitation and emission wavelengths of 585nm and 603nm, 
respectively. The supernatants were then returned to the tubes for the 
next addition of resin.
3.2.2.5 Effect of Incubation Time on Binding
Solution of SR in water (10nM - 1ml) was placed in a microcentrifuge 
tube, to which 25pg resin was added. The samples were spun at 
14,000rpm for five minutes, and then the supernatant was examined 
using an Aminco-Bowman Luminescence Spectrophotometer using 
excitation and emission wavelengths of 585nm and 603nm, 
respectively. The supernatants were then returned to the tubes and 
vortexed thoroughly. The process was repeated over a period of two 
hours to assess the consistency of the binding event over time. 
Treatments used were “No Resin”, “Untreated Resin”, “Amine- 
functionalised Resin”, “Sulfo-SMCC-functionalised Resin”, and “TR401- 
functionalised Resin”.
3.2.3 Final Titration Protocol and Binding Assays
Resin suspension (25pl of 1 mg/ml) was placed in microcentrifuge tube
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and made up to 125pl with distilled water. A solution of SR (330nM) was 
then added by small increments (volumes ranging from 10pl to 100pl, 
summarised in Table 3), thus gradually increasing the amount of SR 
available to the resin. Treatments used were “No Resin”, “Untreated 
Resin”, “Amine-functionalised Resin”, “Sulfo-SMCC-functionalised 
Resin”, and “TR401 -functionalised Resin”; n=4. Tubes were spun at 
10,400G for five minutes, and then the supernatant was examined 
using an Aminco-Bowman Luminescence Spectrophotometer using 
excitation and emission wavelengths of 585nm and 603nm, 
respectively. The supernatants were then returned to the tubes, which 
were vortexed thoroughly for the next addition of SR solution.
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Table 3: Example of SR additions during a binding assay; starting volume is 125pl resin 
suspension to which 330nM SR solution is added.
Volume 
added (til)
Cumulative 
addition (pi)
Total 
volume (til)
Cumulative 
SR addition 
(moles)
Concentration
(nM)
0 0 125 0 0
10 10 135 3.3 E-12 24.44
10 20 145 6.6 E-12 45.52
10 30 155 9.9 E-12 63.87
20 50 175 1.65 E-11 94.29
20 70 195 2.31 E-11 118.46
50 120 245 3.96 E-11 161.63
50 170 295 5.61 E-11 190.17
50 220 345 7.26 E-11 210.43
100 320 445 1.056 E-10 237.30
3.3 Results and Discussion
3.3.1 Linking Chemistry
3.3.1.1 Solution Chem istry -  1
A B
Figure 46: APTES reaction with ninhydrin (A) compared with APTES-Sulfo-SMCC product
reacted with ninhydrin (B).
In Figure 46, tube A contains free APTES reacted with ninhydrin. Tube 
B contains APTES that was reacted with Sulfo-SMCC for one hour at 
room temperature, and then treated with ninhydrin. The reaction of 
amines with the cross-linker shows no colour change with ninhydrin 
treatment, illustrating that the primary amine group has been reacted 
successfully with the NHS-ester of Sulfo-SMCC.
A B
Figure 47: MPTES reaction with Ellman's (A) compared with MPTES-Sulfo-SMCC product
reacted with Ellman's (B).
In Figure 47, tube A shows free MPTES treated with Ellman's reagent. 
Tube B contains MPTES that was reacted with Sulfo-SMCC for one
hour at room temperature, and then treated with Ellman's reagent. Prior 
reaction of sulfhydryls shows no colour change with Ellman's treatment, 
illustrating the successful conjugation of MPTES to Sulfo-SMCC 
through reaction with the maleimide group.
3.3.1.2 Solution Chemistry -  2
Figure 48 shows the shift in excitation and emission spectra of NED 
after reaction with Sulfo-SMCC, the former shifting from 372nm to 
369nm, with the latter shifting from 427nm to 433nm.
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Figure 48: Spectral shifts observed when comparing untreated NED with NED-Sulfo-
SMCC conjugate.
The linking chemistry performed in solution illustrated that Sulfo-SMCC 
was capable of reacting with both sulfhydryl groups and amines as 
hypothesised, in which free amines present on APTES were rendered 
non-reactive with ninhydrin after their exposure to Sulfo-SMCC, 
likewise, MPTES with Ellman's reagent. Also, the excitation and 
emission spectra of NED were altered following conjugation to Sulfo- 
SMCC. This provided the confidence to take Sulfo-SMCC forward into 
peptide-conjugation steps.
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3.3.1.3 Peptide attachment to Merrifield Resin
Initially, TR401 (2mg) was dissolved in distilled water (2ml). UV 
absorbance was measured both before and after incubation with the 
surface-activated resin, which indicated that ~0.5mg TR401 was loaded 
to the surface of 2mg resin.
3.3.2 Development of Binding Assay Protocol
3.3.2.1 Calibration using polypropylene plates
The relationship between the fluorescence emission intensity and 
concentration of SR was shown to be non-linear (Figure 49). Since this 
was not expected, a number of experiments were carried out in order to 
eliminate systematic error, e.g. pipetting errors. Previous studies have 
not made reference to this non-linear response (Miyaki et al., 2005, 
Kumemura et al., 2005), although other studies have raised dispute 
over the quality of calibration standards (Kurebayashi et al., 1993, 
Westerblad and Allen, 1994). So this raises the question as to whether 
it is correct to fit a straight line to the calibration standards, or to use a 
polynomial expression.
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Figure 49: The fluorescence associated with solutions of sulforhodamine 101 in water. 
Filters used were Excitation at 544nm and Emission at 590nm. Each point is an
individual sample.
Although fluorescence quenching at high concentrations is well 
documented (Williams and Bridges, 1964) this low concentration 
biphasic effect is less common although it has been observed with 
some other fluorophores (Krezel and Maret, 2007).
There are a number of possible explanations, including the potential 
that complexes of SR are formed which fluoresce differently from the 
individual molecules. These complexes may only form once a critical 
concentration is reached, resulting in the curve at low concentrations, 
then the linear region thereafter.
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3.3.2.2 Excitation and emission scans of sulforhodamine 
101
Sulforhodamine excitation and emission spectra
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Figure 50: Excitation and emission spectra of sulforhodamine 101 in water.
Excitation and emission maxima were determined as 585nm and 
603nm, respectively. The filters available for the FLUOstar OPTIMA 
were therefore not appropriate for accurate quantification of low levels 
of SR. In subsequent studies fluorescence was measured using the 
Aminco-Bowman Luminescence Spectrophotometer as the required 
wavelengths could be set manually.
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3.3.2.3 Fluorescence Titration
Over the course of the experiment it is obvious from Figure 51 that 
there is some element of quenching as fluorescent intensity drops. 
There is also a shift in the emission peak from the initial 602nm to 
607nm. Such a shift in peak emission wavelength indicates an 
interaction occurring between the fluorophore and another compound 
(Hunt and Ansell, 2006).
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Figure 51: Fluorescence intensity and maximum emission wavelength change as peptide
to SR ratio increases.
After an initial increase, the emission intensity tails off rapidly. This 
quenching effect is also likely to be the result of a direct interaction of 
SR with TR401. Close proximity of the two moieties results in hindrance 
of the passage of light to/from the fluorophore. It is therefore reasonable 
to suppose that there is some form of molecular interaction occurring 
between the two compounds in solution.
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3.3.2.4 Merrifield Resin Titration
Peptide
Resin input amount (ug)
Figure 52: Amount of sulforhodamine 101 bound from aqueous solution upon exposure 
to increasing amounts of Merrifield Resin.
From Figure 52, the TR401-functionalised resin caused a significant 
depletion in SR from solution, whereas there was no apparent change 
in the amount of SR bound to control resins. This clearly demonstrates 
a concentration-dependant binding event between SR and TR401, 
whilst there is no difference between any of the controls. Four replicates 
of each treatment were performed, resulting in a total use of 100pg 
resin at the end of the assay. As the functionalised resin was a precious 
commodity, it was decided not to continue past this quantity, as a 
treatment of 25pg was sufficient for a large difference to be observed.
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3.3.2.5 Effect of Incubation Time on Binding
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Figure 53: Fluorescence associated with sulforhodamine 101 free in solution after 
contact with functionalised Merrifield resin over time; n=1.
The level of SR binding to TR401-functionalised resin reduced over 
time (Figure 53). This could be due to a time-dependant hydrolysis of 
the peptide, resulting in lower availability of binding sites. Therefore, in 
further work, binding was assessed as soon as practicable: less than 10 
minutes. No binding was observed to control resin.
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3.3.3 Binding Assays
An assay was performed to determine binding of SR from solution by 
TR401 -functionalised MR from suspension in water (Figure 54).
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Figure 54: Amount of sulforhodamine 101 bound from aqueous solution by 25gg of 
TR401-functonalised Merrifield Resin (n=4±SD).
Non-linear regression analysis using GraphPad Prism version 5.00 
yielded values for KD and Bmax of 74.87nM and 11.87pmoles, 
respectively, where the model used was:
Bmax x C
Bound = ——----- —
Kd + C
A further assay sought to assess the binding when water was replaced 
with TBS (Figure 55).
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Figure 55: Amount of sulforhodamine 101 bound from TBS by 25pg of TR401- 
functonalised Merrifield Resin (n=4±SD).
Non-linear regression analysis yielded values for KD and Bmax of 
275.8nM and 30.73pmoles, respectively.
This shows a large reduction in binding affinity, but an increase in the 
number of available binding sites when the resin is suspended in TBS 
rather than distilled water. Reasons for this are unclear but may be due 
to the adoption of a different peptide conformation in TBS, albeit a 
conformation which only binds more slowly. TR401 contains a 
tryptophan residue, which can sometimes affect the secondary structure 
of short peptides (Dr. A. Smithson, Peptide Chemist, Severn Biotech, 
Personal Communication -  Appendix 4) and the proportions of each 
conformer can vary depending upon solvent (Appendix 4).
Simply, in this case, the difference observed is, in fact, rather small. 
Bmax is calculated to be 11.87pmoles and 30.73 pmoles for the water-
105
based and TBS-based experiments, respectively. In each case, 25pg of 
resin was used, so the 2.5-fold difference in the number of binding sites 
available may be due to the buffering of the system at pH7.5: an 
important factor to consider in future work.
No differences were observed from controls when the dye was replaced 
with fluorescein, rhodamine 123, or rhodamine 6G.
There was no detectable SR binding when the resin was suspended in 
25%, 50%, or indeed absolute ethanol. This is somewhat disappointing, 
yet unsurprising as the peptide is likely to refold in alcoholic media, 
redistributing charged and uncharged groups in search of the lowest 
energy conformation (Karle et al., 1993). Considering this refolding, it is 
entirely possible that any “binding pocket” present on the peptide has 
been folded away. An interesting step to build in on any subsequent 
experiments in this area would be to dry the resin, return it to water and 
assess any residual binding affinity to determine whether the peptide is 
destroyed or just temporarily hindered. This question is addressed in 
Chapter 4.
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3.4 Further Discussion
Although the error bars shown on Figure 54 and Figure 55 appear 
somewhat large, it is necessary to have an appreciation of the 
error/consistency of the original data.
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Figure 56: Raw data of fluorescence associated with sulforhodamine 101 remaining free 
in aqueous solution upon exposure to 25pg of resin at various concentrations.
Figure 56 shows the raw data, and therefore the intrinsic error, relating 
to the experiment illustrated in Figure 54. Whilst the difference observed 
here is clear when raw data is examined, the error bars appear to 
expand when the data is presented on narrower axes.
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3.5 Conclusions
In conclusion, linking chemistry was developed to functionalise 
Merrifield resin with the glycine-cysteine-modified TR401 and a reliable 
and robust assay was developed which allowed quantification of SR 
binding to the TR401-functionalised resin. A high degree of specific 
binding has been demonstrated between SR and the immobilised 
peptide, as illustrated by the fact that none of the other fluorophores 
exhibited any binding. Binding was not observed in ethanol.
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Chapter 4
Peptide-Conjugated Molecularly  
Imprinted Polymers: 
The Plastibody
“Do not go where the path may lead, 
go instead where there is no path and 
leave a trail. ”
Ralph Waldo Emerson.
4.1 Introduction
The work presented in this chapter sought to combine the high affinity 
and specificity of the peptide derived from phage display with the robust 
and protective properties of a molecularly imprinted polymer.
Polymerisation was controlled using dithiocarboxysarcosine (DTCS, 
Figure 57), a water-soluble photo-iniferter.
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Figure 57: Dithiocarboxysarcosine (DTCS).
Methylene bisacrylamide (MBA, Figure 58) was selected as functional 
monomer as it is known to provide cross-linking functionality (Stevens, 
1999) and should therefore form a cross-linked network in the resultant 
polymer.
o o
Figure 58: Methylene bisacrylamine (MBA).
The solid support employed in these experiments was MR with some 
surface-modification to express 50% primary amines, with the 
remainder of the surface being the native methyl chloride. This allowed 
attachment of TR401 using methods described in Section 3.2.1.3 to the 
amine functionality, whilst allowing attachment of the iniferter through an 
ion-replacement reaction with the chloride group (Qin et al., 2009) 
(Figure 59).
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Figure 59: Reaction of bifunctionalised MR with DTCS to produce iniferter-functionalised
resin.
Having demonstrated in Chapter 3 (Section 3.3.3) that TR401 cannot 
bind SR in ethanol, two issues were presented: firstly that the 
polymerisation environment must be aqueous to allow interaction 
between SR and TR401, and if SR did not bind to TR401 in ethanol, it 
makes a suitable eluent with which to wash SR from the polymer.
The principle aims of this set of experiments were to optimise 
polymerisation conditions and then assess the binding properties of the 
resulting polymers. Specifically, MR was bifunctionalised to express 
DTCS and TR401 together, peptide stability was assessed upon 
exposure to functional monomers, and MR and TR401 were each 
exposed to ethanol to determine its suitability as an eluent. 
Polymerisation experiments were performed with TR401-DTCS 
bifunctionalised resin in the presence and absence of the template SR, 
treatments being referred to as P-MIP and P-NIP, respectively.
4.2 Methods
4.2.1 Functionalisation of Resin
4.2.1.1 Attachment of Iniferter
Merrifield Resin (200-400 mesh, 1% cross-linked with DVB, 1.8-2.0 
mmol Cl/g, Acros Organics -  349160500, BN#A0249177) was 
bifunctionalised to express on the surface equal portions of both 
chloride and amine groups via Staudinger reaction (performed in-house 
by J. Bowen). The resulting bifunctionalised resin (10mg) was 
suspended in distilled water (3ml) and kept stirring while a solution of 
DTCS (manufactured in-house by M. Kelly) (2ml of 25mg/1ml) was 
added dropwise. The reaction mixture was shielded from light and 
maintained at room temperature for 72 hours. The mixture was then 
transferred to microcentrifuge tubes and spun at 10,400G for 4 minutes 
to sediment the resin. The supernatant was discarded, and replaced 
with distilled water. This process of centrifugation was repeated a 
further three times to wash off any unreacted DTCS.
DTCS-functionalised resin was stored in the dark at room temperature 
and used within 48 hours.
4.2.1.2 Attachment of Peptide, TR401
The basic method is as described in Chapter 3 (Section 3.2.1.3) using
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DTCS-functionalised MR with shielding from light. The UV absorbance 
of TR401 solutions pre- and post-reaction were again obtained to 
determine hypothetical peptide-loading to resin. The resulting TR401- 
DTCS bifunctionalised MR construct was then subjected to binding 
assessment as described in Section 3.2.3.
4.2.2 Peptide Exposure to Monomers
A sample of peptide-functionalised MR (500pg) was incubated with a 
solution of MBA (Sigma Aldrich Cat. No.: 146072, Gillingham, UK) 
(1 mg/ml) in distilled water (1ml) in the dark for one hour, washed with 
distilled water either once, or three times, then subjected to a binding 
assay using standard protocol.
4.2.3 Ethanol as Eluent
4.2.3.1 Effect of Ethanol on MR
4.2.3.1.1 Microscopy
A small hole was drilled in a Petri 
dish and a coverslip glued to cover 
the underside of the hole. A small 
amount of resin was then placed 
into the resulting depression and 
observed under a light
microscope. The edges of the Figure 60: Petri dish with drilled hole with
coverslips above and below creating a 
space for an ethanolic suspension of resin.
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depression were then coated thinly with vacuum grease and another 
coverslip was slid across to partially obscure the depression. Ethanol 
(1 OOjjI) was then added to the resin and covered rapidly by sliding the 
coverslip across the remaining aperture. Images were captured under a 
light microscope over a period of 10 minutes. Treatments were 
untreated Merrifield resin, polymerised Merrifield resin, iniferter- 
functionalised Merrifield resin, and polymerised iniferter-functionalised 
Merrifield resin.
4.2.3.1.2 Particle-Size Analysis
Suspensions of untreated Merrifield resin were prepared in water and in 
ethanol and incubated at room temperature for 48 hours before being 
read on a Malvern Instruments Mastersizer 2000 (Malvern, 
Worcestershire, UK).
4.2.3.2 Effect of Ethanol on Peptide
A sample of TR401 (0.5mg) was dissolved in either ethanol or distilled 
water (10ml) and incubated at room temperature for one hour. The 
solvent was then evaporated under vacuum for 30 minutes at 25°C. The 
dry peptide residue was then dissolved in water and subjected to 
chemical linkage to bifunctionalised Merrifield resin as described in 
Section 4.2.1. A binding assay using the standard protocol was 
performed.
Further studies were performed making use of arginine buffer and
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sonication in the search for an efficient elution protocol, summarised in 
Appendix 4.
4.2.4 Polymerisation
Polymerisation mixtures were prepared in HPLC vials containing 100pg 
of the appropriate resin and 1mg methylene bisacrylamide. These 
mixtures then had either 100pl SR solution (6pM) or 100pl water added.
Polymerisation was carried out under UV (A=325nm, 100mW/cm2, at a 
distance of 15cm with the light entering through the glass walls of the 
HPLC vial) and samples were removed at time-points: 
0,1,2,5,10,15,20,30,60,90, and 120 minutes. Each sample was washed 
in ethanol to remove the template and any unreacted monomer. 
Samples were re-suspended in distilled water and SR binding assays 
were carried out as described in Section 3.2.3.
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4.3 Results and Discussion
4.3.1 Functionalisation of Resin
4.3.1.1 Attachment of Iniferter
Attachment of the DTCS was assessed very simply through a change in 
the physical properties of the resin. Bifunctionalised Merrifield resin is 
somewhat hydrophobic (due to the continued presence of methyl 
chloride groups) and therefore does not disperse easily in water; 
whereas once the water-soluble iniferter coats the surface (replacing 
the chloride) the resin forms a very fine suspension easily as 
hydrophobicity decreases. Dry samples were also ground to a fine 
powder and assessed through Fourier-Transform Infrared Spectroscopy 
(FTIR) using a Varian 3100 Excalibur FTIR running the Varian 
Resolutions Pro software.
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Figure 61: FTIR spectra of untreated MR (A), DTCS-coupled MR (B), and DTCS-coupled 
MR exposed to acrylamide under UV for 24 hours (C). FTIR experiments were performed
by J. Bowen and M. Kelly.
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Spectrum (A) in Figure 61 shows untreated MR. Spectrum (B) shows 
DTCS-functionalised MR. The stretches at 1030-1275 indicate the C=S 
bond of DTCS, illustrating that the conjugation has been successful. 
Spectrum (C) shows DTCS-functionalised MR that has been exposed to 
acrylamide under polymerisation conditions. The peak at 1600 is 
indicative of the carbonyl group of acrylamide. This demonstrates that 
DTCS has retained functionality in that polymer growth was achieved.
4.3.1.2 Attachment of Peptide, TR401
Analysis of UV spectra of peptide solutions before and after reaction 
with functionalised Merrifield resin indicates the loss of approximately 
0.232mg TR401 from solution to the resin. Figure 62 shows the result of 
binding assay performed with bifunctionalised Merrifield resin, after 
peptide attachment:
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Figure 62: Sulforhodamine binding assay performed with Bifunctionalised Merrifield 
resin to which TR401 has been linked alongside iniferter. Kd = 2.14nM, Bmax =
3.47pmoles (n=4±SD)
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Loss of 0.232mg TR401 to 1mg resin should result in 3.05nmoles per 
25|jg resin, however, Bmax is 1000-fold below this at only 3.47pmoles. 
This may be as a result of degradation upon storage, although in some 
respects, it is expected that fewer binding sites would be available, as 
only approximately half the surface of the resin has been functionalised 
to receive the peptide. Bmax and KD for these systems are based upon 
the assumption that the binding properties of each peptide unit on the 
surface of the resin are identical. However, stability data for TR401 
(Appendix 5) suggests that fragmentation of the peptide could have 
occurred even before it was conjugated to the surface. Many of the 
surface amine groups may have been occupied by various C-terminal 
fragments of TR401 and not the entire structure.
HPLC analysis of TR401 shows some peak splitting which is likely to be 
the result of the bulky tryptophan residue which can bring about multiple 
folding conformations of the peptide (also Appendix 5). TR401 may 
therefore exist in multiple conformers with different binding properties in 
an aqueous environment.
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4.3.2 Peptide Exposure to Monomers
A comparison is drawn between peptide-functionalised MR that had 
been washed once or three times in water, with peptide-functionalised 
MR incubated in the dark with a monomer solution prior to washing.
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Figure 63: Sulforhodamine binding assays performed with peptide-functionalised resin 
which has either been incubated with MBA solution or with water, then washed either
once or three times (n=4±SD).
It is apparent from Figure 63 that there is a drop in the availability of 
binding sites once the peptide has been exposed to the monomer 
solution. Clearly, in this instance, it is unwise to attempt estimation of KD 
and Bmax as saturation is not reached. However, it is apparent that 
washing the resin three times in distilled water produced a marked 
reduction in binding potential in comparison to a single wash. This is
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likely to be on account of loss of small amounts of resin during the 
washing steps. Incubation with MBA reduced binding further, probably 
through some level of binding to the peptide, which is encouraging for 
further work as the imprinting process should encapsulate the peptide- 
ligand complex.
4.3.3 Ethanol as Eluent
4.3.3.1 Effect of Ethanol on MR
4.3.3.1.1 Microscopy
This study initially sought to visualise the swelling effect of ethanol on 
Merrifield resin with light microscopy.
Figure 64: Example image from the sequence of Merrifield resin exposure to ethanol. No 
size changes were visible of the duration of the experiment (10 minutes). (Scale bar =
65pm)
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Over the course of the experiment (10 minutes) no swelling effect was 
visible for any of the treatments under light microscopy.
4.3.3.1.2 Particle-Size Analysis
MR was suspended in either water or ethanol then analysed using 
Malvern Mastersizer.
25-i
Water
Ethanol20-
0.01 0.1 100 1000 10000100000
Particle size (microns)
Figure 65: Malvern Mastersizer data comparing particle sizes of Merrifield resin after
incubation in water or ethanol.
The Merrifield resin particles were seen to swell only marginally, from a 
mean diameter of 70.72pm to 75.94pm upon exposure to ethanol. This 
equates to spherical volumes of 5235pm3 and 6036pm3, respectively. 
The volume has increased by approximately 15%.
4.3.3.2 Effect of Ethanol on Peptide
Untreated peptide was dissolved in ethanol, dried, and then attached to 
bifunctionalised Merrifield resin. Figure 66 shows the results of the 
subsequent binding assay.
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Figure 66: Binding assay performed using resin functionalised with peptide which had 
been dissolved in ethanol prior to its immobilisation (n=4±SD).
Non-linear regression (Figure 66) yielded Bmax and KD of 4.5pmol and 
15.9nM, respectively, comparative to the values of 3.5pmol and 2.1nM, 
respectively, that were obtained from the aqueous control. While Bmax 
in the low-pmole region is directly comparable, the increase in Kd from 
2.1nM to 15.9nM indicates some slight loss of binding affinity. Although 
peptides are generally stable in ethanol (Guo and Karplus, 1994), there 
may have been some minor damage to the peptide in its recovery from 
the solvent. Whilst an aqueous control was performed in the same 
conditions, the boiling point and relative density of ethanol are both 
lower than water, therefore the conditions when subjected to rotary 
evaporation will no doubt have varied slightly. Whether this subtle 
variation was enough to allow oxidation of side-chains or hydrolysis of 
the peptide is difficult to say.
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4.3.4 Polymerisation
Polymerisation mixtures were prepared and exposed to UV light for the 
times indicated in Table 4. Treatments were Merrifield resin with iniferter 
modification, with or without peptide functionalisation, in the presence or 
absence of SR as a molecular template (P-MIP, P-NIP, MIP, or NIP).
Full binding isotherms are shown in Appendix 6. Summary data shown:
Table 4: Summary of Kd and Bmax values for sulforhodamine binding assays carried out 
at varying P-NIP polymerisation times.
Polymerisation Time 
(minutes)
KD(nM) Bmax (pmoles)
0 94.24 36.26
1 212.1 62.55
2 240.1 55.12
5 177.0 46.69
10 150.6 50.79
15 193.5 53.93
20 100.5 35.33
30 13.75 3.46
60 51.10 12.39
90 35.63 10.23
120 94.49 29.44
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Table 5: Summary of Kd and Bmax values for sulforhodamine binding assays carried out 
at varying P-MIP polymerisation times.
Polymerisation Time 
(minutes)
KD(nM) Bmax (pmoles)
0 420.6 13.00
1 6436 114.4
2 317.1 31.27
5 2111 132.8
10 135.2 28.75
15 ~ ~
20 ~ ~
30 50.51 11.75
60 ~ ~
90 ~ ~
120 190.1 41.29
Whilst binding assays were performed for all polymerisation treatments, 
some polymers either showed no binding affinity at all, or the data 
would not fit standard non-linear regression models; this accounts for 
the missing values in Table 5. Data is presented in full in Appendix 6.
4.3.4.1 Key Observations
Figure 67 shows the binding isotherm plotted from the bifunctionalised 
resin 20-minute polymerisation treatment in the absence of SR as 
template.
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Figure 67: Sulforhodamine binding assay at optimal polymerisation time for P-NIP
(n=4±SD).
Kd and Bmax were determined as 100.5nM and 35.33pmoles, 
respectively.
Figure 68 shows the binding isotherm plotted from the 120-minute 
polymerisation treatment with the inclusion of SR as template. KD and 
Bmax were determined as 190.1nM and 41.29pmoles, respectively. 
These figures represent the optimum conditions for producing TR401- 
polymer constructs with the greatest overall binding potential (low KD 
and high Bmax).
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Figure 68: Sulforhodamine binding assay at optimal polymerisation time for P-MIP
(n=4±SD).
Interestingly, the P-MIP exhibits higher values for both KD and Bmax 
when compared to P-NIP. This is contrary to the hypothesis that an 
imprinted system would show higher binding affinity and greater 
availability of binding sites when compared to a non-imprinted control. 
Therefore, it is likely that some template remains trapped in the 
imprinted matrix and an improved washing protocol must be developed 
for more thorough elution.
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Figure 69: Sulforhodamine binding to Peptide-functionalised, iniferter-derivatised 
Merrifield resin. Ko 370.OnM, Bmax 286.4pmoles (n=4±SD).
Figure 69 shows the result of a binding assay using TR401-DTCS 
bifunctionalised resin, without polymerisation. KD and Bmax are both far 
higher than TR401-resin alone: KD 370.0nM compared to 2.141 nM, and 
Bmax 286.4pmoles compared to 3.47pmoles. The far higher Bmax 
indicates greater coverage of the MR surface with functional TR401; 
although the increase in KD (binding affinity falling) is less easily 
explained. KD, of course, is a parameter describing a combination of 
effects: the rate at which binding complexes are formed, and the rate at 
which they dissociate again. If the rate of formation of these complexes 
(Kon) remains constant, but the rate of dissociation (K0ff) increases, Kd 
rises. Likewise, if K0ff remains constant but Kon decreases, this will 
cause a drop in KD. Any interaction of DTCS with TR401 or with SR is 
likely to influence either, or both, of these rates.
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No binding was evident to the non-peptide, non-imprinted polymer 
treatments at any time-point, whereas, at later points the non-peptide 
molecularly imprinted polymer treatment began to show some level of 
binding, albeit very low comparative to the peptide treatments (data 
shown in Appendix 6).
Ethanol control
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Figure 70: Peptide-functionalised, iniferter-derivatised Merrifield resin washed in ethanol
(n=4±SD).
When TR401-DTCS bifunctionalised resin was washed in ethanol 
(Figure 70), the binding capability of the peptide appeared to be almost 
completely removed, whereas, some degree of polymerisation as 
demonstrated in the P-MIP and P-NIP treatments retained binding to a 
high degree.
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Table 6: Summary of Kd and Bmax for the peptide-polymerisation treatments under
optimum conditions.
Kd (nM) Bmax (pmoles)
TR401-DTCS
resin
370 286.4
Ethanol washed 
peptide-resin
N/A N/A
P-MIP 190.1 41.29
P-NIP 100.5 35.33
Both P-NIP and P-MIP appear to bind with greater affinity than peptide- 
functionalised resin (KD 370nM). However, the total number of binding 
sites available appears to drop once polymerisation is initiated. The 
TR401-functionalised MR demonstrates a Bmax of 286.4pmol, whereas 
P-NIP and P-MIP have values of 35.3pmol and 41.3pmol, respectively.
This would suggest that although the peptide that remains after the 
polymerisation process appears to bind with higher affinity than before 
polymerisation, a great deal of damage is done to the peptides and only 
a small proportion of peptide molecules survive the process.
4.4 Further Discussion
A wash in ethanol of the TR401-functionalised resin renders the 
attached peptide non-binding, but the resin-swelling effect caused by 
ethanol is low, and ethanol does not damage the peptide alone. As
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binding was evident to P-NIP and P-MIP it is surmised that the 
polymerisation process is in some way conferring protection to the 
peptide, as the surfaces were not damaged by the ethanol wash. 
Perhaps there is a conformation the immobilised peptide favours in 
ethanol which cannot be recovered upon its return to water. The 
presence of the supportive polymer shell may hinder these 
conformational changes of the peptide. As described in Section 3.4, 
HPLC analysis of TR401 (presented in Appendix 4) indicates that 
choice of solvent may affect the conformation of peptides with bulky 
residues such as tryptophan.
The value for Bmax obtained from the assays in which TR401 was 
conjugated to bi-functionalised MR was 3.47pmoles. However, if the bi- 
functionalised resin had first been treated to express DTCS, Bmax was 
far higher at 286.4pmoles. The amount of resin in each assay was, of 
course, the same (25|jg), so the question is raised as to what could be 
causing such an increase in Bmax. In the case of bi-functionalised 
resin, primary amines were conjugated to TR401 (reaction scheme 
illustrated in Figure 71). The remainder of the surface is methyl chloride. 
However, in the case of the TR401-DTCS-functionalised resin, the 
chloride groups that had been present on the surface have been 
replaced with hydrophilic iniferter species. Indeed, the very presence of 
DTCS on the surface of the resin may have resulted in greater access 
of TR401 to the surface during the conjugation step, as the surface was
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more hydrophilic.
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Figure 71: Reaction scheme showing the production of TR401-DTCS bi-functionalised
Merrifield Resin.
4.5 Conclusions
The binding affinity of TR401 to SR appeared greater in the polymerised
systems than the non-polymerised system, although the extent of that
binding (Bmax) has been greatly reduced. It is likely that, in general,
damage is occurring to the surface-immobilised peptides, although
those peptide units which escape this damage bind with higher affinity
than peptide alone. Basic proof-of-principle is demonstrated in that a
peptide derived from phage display was incorporated into a molecular-
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imprinting system and retained binding affinity for its target. Moreover, 
the binding affinity (KD) was slightly improved for the polymerisation. 
However, this does, of course, require much optimisation with regard to 
polymerisation conditions and components. Additionally, an improved 
washing regime must be devised, as the results shown in Section
4.3.4.1 suggest that the binding sites of P-MIP may still be occupied 
with template SR included in the polymerisation stage.
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Chapter 5
General Discussion
“Nothing shocks me. I ’m a  scientist. ”
Harrison Ford, as Indiana Jones
The principle aim of this project was to produce a peptide-MIP 
conjugate which showed higher affinity and specificity to a given target 
than is currently possible with imprinted polymer technology alone, 
whilst being more robust than simple peptide-binding systems or indeed 
antibody-based systems.
5.1 Phage Display
The intention had been to begin with a phage display library and take 
the technology through from start to finish. However, the panning 
against propranolol failed to yield binding consensus sequences. The 
underlying strategy of screening the phage library against low molecular 
weight molecules and using structurally-related compounds to optimise 
selection for the target is not unknown (Smith et al., 2007), and logic 
would suggest that the use of competing compounds in solution whilst 
panning against a sedimentary surface should have yielded peptides 
with high specificity. One possibility for the failure of the panning is that
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this level of stringency from the outset was too high. Comparative to the 
scale of the library (109 unique units), the inoculation of phage at each 
round was 1011 particles, around 100 copies of each displayed peptide. 
If round one was too stringent, any strongly binding peptides with lower 
specificity will have been excluded, whilst peptides with moderate 
binding affinity (which would still have been useful in later studies) were 
discarded with the competing compounds in solution, das Kind mit dem 
Bade ausschOtten (German Proverb, c.1512). Another possible issue 
with panning against small molecules is that they present too few 
functional groups in the target to select for high affinity binding peptides.
Reports of phage display against small molecular targets include 
paracetamol (Smith et al., 2007), dexamethasone (Yu et al., 2007) and 
methotrexate (Takakusagi et al., 2008) (structures shown in Figure 72) 
with paracetamol having the simplest of structures and the least 
complex to serve as a target (see Table 7). Indeed, personal 
communication (M. Gumbleton and M.W. Smith (Smith et al., 2007)) 
indicated that the peptide-phage identified for paracetamol did not show 
a high degree of consensus in the peptide sequences and the affinities 
were not high. Propranolol also offers limited chemistry for peptide- 
phage panning compared to methotrexate and dexamethasone.
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Figure 72: Paracetamol (A), dexamethasone (B), and methotrexate (C).
Table 7: Properties of the low molecular weight phage display biopanning targets.
Compound Mw LogP
H-bond
Donors
H-bond
Acceptors
Asymmetric
Centres
Propranolol 259.3 3.35 2 3 1
Methotrexate 454.4 0.94 5 9 1
Dexamethasone 392.5 -0.21 3 5 8*
Paracetamol 151.2 0.28 2 3 0
*Whilst dexamethasone contains eight asymmetric centres, “dexamethasone” refers only
to a single conformation.
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Further, there is potentially a stereochemical issue in the choice of 
suitable targets for phage display. Whilst methotrexate has a chiral 
centre, it is located well away from the region of the molecule expected 
to bind to the isolated peptide, or indeed to the drug’s target in the body 
(dihydrofolate reductase (Takakusagi et al., 2008)). The methotrexate 
study, in fact, made use of biotinylated methotrexate, although the 
authors do not specify through which functional group the biotin was 
attached. There is the possibility that the compound was immobilised 
such that the chiral centre would have little importance in the regions of 
the molecule exposed to the phage.
Figure 73: Propranolol.
Biopanning against propranolol (Figure 73), however, was either as 
free-base suspension, or immobilised through the naphthyl group to 
glass beads. This would result in exposure of the chiral centre to phage, 
which brings with it the possibility that there was simultaneous selection 
occurring for two targets: R/S-propranolol. An interesting observation at 
this stage is that one of the peptide-phage clones isolate from the 
suspension-panning experiment (Section 2.2.4.1) had the sequence 
EMTSTRA. This clone was retained when exposed to propranolol
covalently attached to glass beads (Section 2.2.4.2) (Outputs 1 & 2 
from Figure 16). A single clone with the sequence EPRATST was 
recovered from the experiment in which propranolol was attached to 
glass beads. This presence of EMTSTRA and EPRATST sequences in 
separate biopanning experiments against a racaemic target may be 
indicative of peptides selective for individual enantiomers, although, 
unfortunately, no binding for these peptides was observed in any of the 
assay methods employed.
Several of the assay formats presented in Chapter 2 made use of 
materials which were subsequently found to bind propranolol. This 
highlights the importance of a thorough understanding of the 
substances and materials in use, and especially their limitations. The 
final binding assay protocol in Chapter 2 was the micro-centrifuge tube 
dialysis system. This was, by far, the most accurate system to 
determine propranolol concentrations at equilibrium, but even this was 
not perfect. There was still a low level of binding to the dialysis 
membrane which may have influenced experimental outcome.
Many phage display studies make use of technologies such as quartz 
crystal microbalance (QCM) (Wu et al., 2010, Hengerer et al., 1999) or 
surface plasmon resonance (SPR) (Swain Md Fau - Anderson et al., 
2010, Weiger et al., 2010) both during biopanning and in subsequent 
peptide-phage binding assessments. These techniques are very
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sensitive and can readily detect phage binding to an immobilised target; 
however, a functional group is lost in the immobilisation of the target. 
When assessing a molecule with as few functional groups as 
propranolol, any loss of functionality is undesirable.
A suitable target for biopanning with peptide-phage display would have 
a variety of functional groups, and would not display non-specific 
binding to experimental materials. If looking to medicinal drugs, plasma 
protein binding may give an indication as to whether this is likely.
OH
Figure 74: Sotalol.
A compound such as sotalol (LogP = -0.06) which is not bound in 
human plasma (Carr et al., 1992) would be much more appropriate, 
although sotalol (Figure 74) also contains a chiral centre, and therefore 
a single enantiomer should be considered.
5.2 TR401
When faced with the failure to produce a novel peptide, an example 
was chosen from the literature. TR401 is a peptide that binds Texas
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Red and which was further characterised with respect to its binding 
capabilities in Chapter 3 of this thesis. TR401 was selected because the 
initial intention was to obtain a peptide from phage display with high 
affinity and specificity to a low molecular weight compound.
Although their original paper (Rozinov and Nolan, 1998) performed 
biopanning against Texas red, Rhodamine red, Oregon green 514, and 
fluorescein, TR401 was found to be the phage-derived peptide with 
highest affinity for its target (Texas Red). Rozinov and Nolan performed 
several experiments to determine KD for the TR401-Texas Red 
interaction which they quoted as 0.27nM when peptide was in situ on 
the phage and 1.6pM for the synthetic peptide immobilised to magnetic 
beads via a histidine-tag. This illustrates clearly that KD is a constant 
that is specific for a given system and therefore it was necessary to gain 
a thorough understanding of how TR401 behaved when attached to the 
Merrifield Resin support.
High levels of binding were seen when TR401-functionalised MR was 
exposed to sulforhodamine, both in distilled water and in TBS (KD = 
74.87nM, and 275.8nM, respectively), and this provided both a baseline 
to which comparison could be drawn for any binding observed once 
polymerisation was brought into the system, and confidence to proceed 
to the next stage of the project.
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5.3 Peptide-Molecular Imprinted Polymers
Table 6 in Chapter 4 (Summary of KD and Bmax for the peptide- 
polymerisation treatments under optimum conditions) shows an 
increase in binding affinity (reduction in KD) in P-MIP and P-NIP 
treatments compared to non-polymerised peptide-functionalised resin, 
although the values attained for Bmax and KD are similar for both P-NIP 
and P-MIP This is not surprising as both treatments underwent TR401- 
conjugation in an identical manner, so should therefore have the same 
overall number of binding sites. The data suggest that the imprinting 
process is not, in fact, assisting with the formation of a binding site as 
would be expected when considering previous MIP literature (i.e. 
polymer interaction with the template). However, there is also a large 
drop in the number of available binding sites, so the overall binding 
potential of the system is compromised. This may be the result of the 
polymer growing across the peptide, causing the binding sites to be 
lost. Additionally, electron-rich amino acid residues are likely to be 
vulnerable to free-radical attack, which may damage the peptide 
irrecoverably. This may explain why some of the polymerisation 
treatments failed to demonstrate any binding whatsoever.
The structure of the polymer should have some degree of cross-linking 
due to the choice of methylene bisacrylamide as a cross-linking 
monomer, which was chosen for its ability to produce highly cross- 
linked structures. This would confer some degree of rigidity to the final
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polymer and restrict any swelling effect when immersed in liquids 
(Nielsen, 1969). However, when growing a polymer from a surface- 
bound initiator, the degree of cross-linking may be reduced comparative 
to standard di-methacrylate cross-linking, and may require a tri­
methacrylate (Deng et al., 2009).
Additionally, as the polymer was growing from a surface, rather than 
forming as pre-defined droplets in emulsion/suspension or as a bulk 
monolith, there is the possibility that it will reach a critical size and then 
collapse under its own weight. However, this is purely conjecture, and 
binding affinity was seen to be restored after further polymerisation. 
Clearly further investigation into the polymerisation protocol is called for.
As shown briefly in Figure 70, an ethanol wash of TR401-DTCS 
bifunctionalised resin appears to completely remove any ability of the 
surface-bound peptide to bind SR from solution. The resin was tested 
for swelling effects in ethanol, and TR401 was assessed for peptide 
stability; yet, the swelling effect of ethanol on MR was only marginal, 
and TR401 which had previously been dissolved in ethanol bound SR 
once conjugated to the MR surface. Therefore, the nature of the effect 
of ethanol on the TR401-functionalised MR system is currently 
unexplained. However, once polymerisation was initiated in the system, 
resistance to the ethanol wash seen. This implies direct interaction of 
the polymer with both the peptide and the resin support, conferring
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stability and allowing some of the surface-immobilised TR401 to remain 
in a binding conformation.
5.4 Future Work
A starting point for future work would be the elucidation of the exact 
nature of the effect ethanol has on the peptide-functionalised resin by 
allowing a slower change in ethanol/water proportions to ascertain 
whether binding can be reinstated.
An effective washing regime must then be devised. This is evinced by 
the fact that the binding constants associated with P-NIP suggest 
greater binding ability than P-MIP, which is contrary to hypothesis. This 
is likely to be as a result of continued occupation of binding sites by 
template molecules which have resisted current washing efforts.
A large drop in Bmax is observed in the polymerised treatments when 
compared to non-polymerised control. This is likely to be the result of 
damage to the surface-bound peptide during the polymerisation and 
washing processes. The question must be addressed as to whether any 
resulting peptide damage has affected specificity. Further experiments 
should be performed to challenge P-NIP and P-MIP with related 
compounds (rhodamine-6G, rhodamine-123, and fluorescein) in an 
effort to determine any cross-sensitivity induced by the polymerisation.
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Variation in polymer constitution should also be considered. There is a 
large range of compounds that are widely used in imprinting science 
(White and Byrne, 2010, Lasakova and Jandera, 2009, Holthoff and 
Bright, 2007) and further studies should consider the use of a wider 
variety of potential components, for example the use of a more complex 
functional monomer with a larger variety of functional groups, and the 
use of a trisacrylamide cross-linker to provide a more stable three- 
dimensional structure.
5.5 Conclusions
As the resulting polymers from many of the treatments exhibited 
binding, where the non-polymerised control did not, this goes some way 
towards supporting the original hypothesis, although further work is 
essential. Whilst the resultant peptide-polymer conjugates have shown 
a certain resistance to ethanol washing, further testing of their 
limitations is desirable, e.g. subjection to high temperatures, 
acidic/basic conditions, or enzymatic attack.
Although there are several studies in which peptides have been 
conjugated to polymers for various purposes (Veronese and Morpurgo, 
1999, Jain and Jain, 2008, Magnusson et al., 2010), the concept of 
using a binding peptide in the imprinted cavity of a MIP system is 
entirely new.
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The very nature of the technology of phage display can produce binding 
peptides with high specificity, given a suitable biopanning protocol, yet 
any effect that polymerisation has on that specificity should be 
considered.
Overall, the work presented here, the first of its kind, provides proof-of- 
principle towards the concept of the peptide-conjugated molecularly 
imprinted polymer: The Plastibody.
• A peptide can survive free-radical-based polymerisation.
• It can retain binding ability.
• The polymer shell confers some protection.
Further work in this area may lead to the development of a truly 
biomimetic artificial antibody for use in myriad applications wherever a 
high degree of binding affinity and specificity are called for, whether it’s 
the detection of biological hazards, environmental threats, diagnostic 
testing, imaging, drug delivery, or therapeutic agents in their own right.
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Appendix 1
Peptide Sequences Isolated from Phage Display 
Against Propranolol
Peptide 1 -  EMTSTRA
Figure 75: Sequence 1: EMTSTRA (Glutamic ac id-M ethionine-Threonine-Serine- 
Threonine-Arginine-Alanine).
Glutamate (E) is polar with a negative charge at physiological pH. 
Methionine (M) is hydrophobic. Threonine (T) is very small, and whilst a 
hydroxyl group is present the amino acid is generally hydrophobic. 
Serine (S) is very small and slightly polar. Arginine (R) is polar and 
takes a positive charge at physiological pH. Alanine (A) is very small
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and slightly hydrophobic.
This clone was present as 14.4% of the successfully sequenced 
population in the experiment in which the phage library was exposed to 
propranolol free base as an insoluble complex. It was also present as 
8.0% of the successfully sequenced population in the experiment in 
which the pre-screened phage populous was exposed to propranolol 
covalently bound to glass beads.
Peptide 2 -  NANNRLY
Figure 76: Sequence 2: NANNRLY (Asparagine-A lanine-Asparagine-Asparagine-Arginine-
Leucine-Tyrosine).
Asparagine (N) is the predominant amino acid residue in this peptide; it 
is very small and polar, expressing a slight negative charge at 
physiological pH. Alanine (A) is very small and slightly hydrophobic.
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Arginine (R) is polar and takes a positive charge at physiological pH. 
Leucine (L) is an aliphatic, hydrophobic residue. Tyrosine (Y) is 
aromatic and, whilst slightly polar, tends towards hydrophobicity.
This clone was present as 4.1% of the successfully sequenced 
population in the experiment in which the phage library was exposed to 
propranolol free base as an insoluble complex. It was not present in the 
successfully sequenced population in the experiment in which the pre­
screened phage populous was exposed to propranolol covalently bound 
to glass beads.
Figure 77: Sequence 3: PAQDPRY (Proline-Alanine-Glutam ine-Aspartate-Proline-
Arginine-Tyrosine).
Peptide 3 -  PAQDPRY
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Proline (P) is a very small aliphatic residue. Alanine (A) is very small 
and slightly hydrophobic. Glutamine (Q) is polar and very hydrophilic. 
Aspartate (D) is polar, expressing a negative charge at physiological 
pH. Arginine (R) is polar and takes a positive charge at physiological 
pH. Tyrosine (Y) is aromatic and, whilst slightly polar, tends towards 
hydrophobicity.
This clone was present as 1.0% of the successfully sequenced 
population in the experiment in which the phage library was exposed to 
propranolol free base as an insoluble complex. It was also present as 
4.0% of the successfully sequenced population in the experiment in 
which the pre-screened phage populous was exposed to propranolol 
covalently bound to glass beads.
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Peptide 4 -  QIKHRHM
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Figure 78: Sequence 4: QIKHRHM (Glutamine-lsoleucine-Lysine-Histidine-Arginine-
Histidine-Methionine).
Glutamine (Q) is polar and very hydrophilic. Isoleucine (I) is aliphatic 
and largely hydrophobic. Lysine (K), whilst expressing a positive 
charge at physiological pH, is also largely hydrophobic. Histidine (H) 
has a five-membered nitrogen-containing aromatic ring which can 
accept a positive charge although the residue remains hydrophobic. 
Arginine (R) is polar and takes a positive charge at physiological pH. 
Methionine (M) is hydrophobic.
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This clone was present as 4.1% of the successfully sequenced 
population in the experiment in which the phage library was exposed to 
propranolol free base as an insoluble complex. It was also present as 
4.0% of the successfully sequenced population in the experiment in 
which the pre-screened phage populous was exposed to propranolol 
covalently bound to glass beads.
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Appendix 2
Fluorescent Properties of Suiforhodamine 
A2.1 Introduction
The experiments in this section assessed the alteration of fluorescence 
filters, together with the material and colour of the plates. Detection limit 
was assessed alongside the effect of “gain” on linearity of the resulting 
calibration curve. Incubation with various materials was carried out and 
the effect upon fluorescence observed. The overall objective was to 
thoroughly test the fluorescent properties of SR with a view to the 
construction of suitable assay methodology to allow accurate and 
consistent quantification of the compound during binding assessments.
A2.2 Methods 
A2.2.1 Detection limit of Suiforhodamine 101 using 
FLUOstar OPTIMA
Standard solutions of SR in distilled water were prepared ranging from 
0.001 nM to 25nM. Aliquots (200pl) were placed into a black polystyrene 
96-well plate (Nunc, Thermo Scientific) and read in the FLUOstar 
OPTIMA (BMG Labtech, Offenburg, Germany) using an excitation filter 
at 544nm and emission filter of 590nm. Four replicates of each
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concentration were examined.
A2.2.2 Effect of “Gain” on Suiforhodamine Calibration 
Linearity
Standard solutions of SR in distilled water were prepared ranging from 
25nM to 500nM. Aliquots (200pl) were placed into a black polystyrene 
plate and read in the FLUOstar OPTIMA using an excitation filter at 
544nm and emission filter of 590nm. Four replicates of each 
concentration were examined. The highest concentrations (250nM and 
500nM) were then discounted from the plate layout and the sensitivity of 
the plate-reader was then reset based on the 10OnM sample. The lower 
points were then read again.
A2.2.3 Influence of Plate Colour and Filter
Standard solutions of SR in distilled water were prepared ranging from 
10nM to 100nM. Aliquots (200ul) were placed into black or white 
polystyrene 96-well plates and read in the plate-reader using both 
544nm and 580nm excitation filters, and both 590nm and 610nm 
emission filters.
A2.2.4 Binding of Suiforhodamine to Experimental 
Materials
Standard solutions of SR in distilled water were prepared ranging from
10nM to 1000nM. Aliquots (300pl) were then placed into polypropylene
plates, polystyrene plates or glass multi-dose vials for 24 hours at room
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temperature. Samples were then taken (200pl) and transferred to black 
polystyrene plates and read in the FLUOstar OPTIMA (Ex 544nm; Em 
590nm).
A2.2.5 Repeated readings and binding to polystyrene 
plates
Standard solutions of SR in distilled water were prepared ranging from 
20nM to 100nM, and 200pl aliquots were placed into a polystyrene plate 
such that eight rows contained an identical standard sequence. All 
readings took place in the FLUOstar OPTIMA (Ex 544nm; Em 590nm). 
The first row (Row A) was read every time the plate was returned to the 
instrument, whilst the subsequent rows were only read once after an 
appropriate period of incubation. Row B was read after 10 minutes, 
Row C after 20 minutes, Row D after 30 minutes, Row E after 60 
minutes, Row F after 120 minutes, Row G after 180 minutes, and Row 
H after 24 hours.
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A2.3 Results
A2.3.1 Detection limit of Suiforhodamine 101 using 
FluoSTAR OPTIMA
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Figure 79: The fluorescence associated with low concentrations of suiforhodamine 101. 
Mean and standard deviation are shown, n=4. Ex 544nm, Em 590nm.
In Figure 79, “A” depicts a range of concentrations on a log scale. “B” 
shows a repeated reading of the lower concentrations, with the 
sensitivity of the plate-reader greatly increased in an effort to distinguish 
the lower-most points. This demonstrates that, even at high sensitivity, 
the quantifiable limit (5:1 signal-to-noise ratio) of SR in the FLUOstar 
OPTIMA is in the region of 10nM, where a sample is 200pl. This 
equates to approximately 2.0 pmoles per well. Whilst lower amounts 
can be detected, they are not significantly different from vehicle-only 
controls or indeed empty wells, so cannot be quantified.
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A2.3.2 Effect of “Gain” on Suiforhodamine Calibration 
Linearity
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Figure 80: The fluorescence associated with low concentrations of suiforhodamine 101. 
Mean and standard deviation are shown (n=4). In graph A, the sensitivity of the plate- 
reader is given as 2476. In graph B, the sensitivity is increased to 3141. In each case the 
instrument settings were determined automatically to place the highest data point at 90%
of the capacity of the instrument.
As illustrated by Figure 80 the sensitivity of the instrument does not 
appear to have any effect on the distribution of data points in this 
instance.
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A2.3.3 Influence of Plate Colour and Filter
Figure 81 shows SR calibration standards in black plates.
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Figure 81: The fluorescence associated with solutions of suiforhodamine 101 in water -  
in black piates. Filters used were Excitation 544nm and Emission 590nm in A; Excitation 
580nm and Emission 610nm in B. Graphs shown mean and standard deviation (nM).
There appears to be very little difference between the two curves,
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although the level of variance is slightly greater when using Excitation at 
580nm and Emission at 610nm (graph B above).
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Figure 82: The fluorescence associated with solutions of suiforhodamine 101 in water -  
in black plates. Filters used were Excitation 544nm and Emission 610nm. Graph shows 
mean and standard deviation (n=4).
These data are directly comparable with the data obtained from the 
black plates above. When using excitation of 544nm and reading 
emission at 610nm the mean fluorescence values stay approximately 
the same, although far greater variability is seen.
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Figure 83 shows SR calibration standards in white plates.
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Figure 83: The fluorescence associated with solutions of suiforhodamine 101 in water -  
in white plates. Filters used were Excitation 544nm and Emission 5d0nm in A; Excitation 
580nm and Emission 61 Onm in B. Graphs shown mean and standard deviation (n=4).
Again, Figure 83 shows there is little difference between the two filter 
methods when using the white plates. Although, an interesting 
observation is that the calibration lines associated with the white plates
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appear to curve as if approaching a plateau. The gain was automatically 
determined by the instrument in each case, based on the well with the 
greatest fluorescence intensity. The black plates induced a gain of 2844 
and 2875 for graphs A and B in Figure 81 respectively, whilst the white 
plates brought about gain values of 1479 and 1431 for graphs A and B 
in Figure 83 respectively. This would imply that far greater amounts of 
light were available when using the white plates as the surface is, of 
course, more likely to reflect. It is possible that auto-quenching is 
already being approached at only 100nM.
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A2.3.4 Binding to Experimental Materials
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Figure 84: The fluorescence associated with solutions of sulforhodamine 101 in water 
after incubation with a range of materials. Filters used were Excitation 544nm and 
Emission 590nm. Graphs shown mean and standard deviation (n=4).
It is evident from Figure 84 that whilst little or no binding occurs with 
polypropylene in comparison with glass, a large proportion of SR is lost 
in non-specific binding to polystyrene.
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A2.3.5 Repeated readings versus binding to polystyrene 
plates
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Figure 85: The fluorescence associated with sulforhodamine 101 solutions in water upon 
repeated reading over time (A) and single readings with incubation time alone (B). Filters 
used were Excitation 544nm and Emission 590nm.
There appears to be little or no difference between the graphs A and B 
above, indicating that time spent in the polystyrene plate is the 
overriding factor in the decrease in fluorescence intensity. This is 
unsurprising given that SR exhibits a high degree of non-specific
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binding to polystyrene. Repeated readings appear to have little or no 
effect in comparison with regard to photobleaching.
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Appendix 3
Preparation of Glass Surfaces Prior to 
Immobilisation of TR401
A 3.11ntroduction
This set of experiments was intended to allow immobilisation of the 
peptide TR401 via either the N-terminal lysine residue or by the unique 
sulfhydryl group present on the C-terminal cysteine residue. It was 
hoped that comparisons could be drawn which would enable a better 
understanding of the binding event with a view to influencing the 
peptide orientation in the final polymer product.
A3.2 Methods 
A3.2.1 Surface Functionalisation
Glass microscope slide cover slips were cleaned using two sonication 
steps: 15 minutes in ethanol, followed by 15 minutes in
dimethylformamide (DMF). They were then dried under clean, flowing 
nitrogen. The cover slips were then activated using piranha solution. 
Briefly, they were placed into a small Petri dish and covered using 
concentrated sulfuric acid (7ml). Hydrogen peroxide (30% - 3ml) was 
added dropwise to produce the piranha solution which was kept at
176
approximately 80°C for 20 minutes, then allowed to cool for a further 10 
minutes. The cover slips were then washed three times in distilled 
water, for 10 minutes each time, then dried under nitrogen.
Evaporation was carried out using a 50%w/w solution of either 3- 
aminopropyltriethoxysilane (APTES) (Sigma, A3648) or 3- 
mercaptopropyltriethoxysilane (MPTES) (Fluka, 63797) in paraffin oil 
(Fisher, P/0320/17) in an upturned lid from a microcentrifuge tube 
(shown in Figure 86). This was placed in a small Petri dish at room 
temperature with the cover 
slips to allow evaporation for 
five minutes each side. The 
cover slips were then
transferred to acetone and
sonicated for 10 minutes, 
given two further 10 minute 
washes with acetone without 
allowed to cure in a drying oven
The majority of this linking chemistry is readily transferable to glass 
beads instead of flat cover slips, with the exception of the initial 
evaporation steps. This was replaced with a 24 hour reflux in toluene 
with 2% w/w APTES or MPTES.
Figure 86: Layout of the evaporation process, 
showing the glass coverslips arranged around 
the upturned microcentrifuge tube lid, encased 
within a Petri dish.
sonication, dried under nitrogen then 
overnight.
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A.3.2.2 Confirmation of surface alteration 
Atomic Force Microscopy
Treated glass cover slips were incubated in a solution of gold 
nanoparticles (Sigma, G1527 [~0.75A52o units/ml] 10nm diameter) for 
24 hours at room temperature in the dark. They were then washed 
three times in large volumes of distilled water, dried under nitrogen, and 
the surfaces observed using a Veeco Scanning Probe Microscope 004- 
130-000.
Contact Angle Observation
The pre-treated glass cover slips were placed on a surface level with 
the centre of the lens of a camera (Nikon D50 SLR). A small drop of 
ddH20  (2pl) was then placed on the surface and a photograph taken.
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A 3 .3  R e s u lt s
Linking C h em istry  -  AFM  and contact angles
Treatment Predicted Structure 
AFM image | Contact Angle
Piranha solution 
activated
-to SI O H -H O  Si OH HO SI— OH------- HO Si OH-
H H H H
' %
. \  ■
Evaporation of 
APTES
HO------Si— OH—HO— Si— OH HO——Si-
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Sulfo-SMCC linkage
Table 8: Amine activated surfaces, prepared to connect to the TR401-modified peptide via 
the sulfhydryl group on the C-terminal cysteine residue.
As shown in Table 8, the piranha solution-activated glass surface is 
highly hydrophilic and does not attract the gold nanoparticles from 
suspension, however, once evaporated with APTES, a slight drop in 
hydrophilicity is seen (water contact angle) and the AFM image shows a 
surface well-populated with gold nanoparticles. Sulfo-SMCC linkage 
appears to decrease hydrophilicity further and make the deposition of 
gold more erratic.
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Treatm ent
Piranha solution 
activated
Predicted Structure  
AFM image | Contact Angle
OHI
lO  SI O H -H O  SI OH HO SI— OH------- HO Si-
H H H H
' .
Evaporation of 
M P T E S
■lO Si O H -H O  Si OH
’ .
'
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O N»+
Sulfo-SMCC
linkage
Table 9: Sulfhydryl activated surfaces, prepared to connect to the TR401-modified 
peptide via the amine group on the N-terminal lysine residue.
Table 9 shows a piranha solution-activated glass surface very similar to 
that shown in Table 8. However, evaporation of MPTES results in a very 
hydrophobic surface (water contact angle) and the AFM image shows a 
surface which still does not attract gold nanoparticles. Sulfo-SMCC 
linkage appears to increase hydrophilicity once more further and is 
comparable to the surface seen in Table 8.
Whilst the data presented indicate that successful conjugation of TR401 
to glass surfaces is possible, a binding assay using the protocol 
described in Chapter 3 (3.2.3) showed no significant difference in the 
amount of sulforhodamine 101 bound by TR401-functionalised glass
beads from controls. This may, in part, be due to decomposition of the 
peptide-glass linkage throughout the course of the experiment, or, more 
likely, that the surface area of the glass bead is simply too small to 
immobilise a sufficient amount of TR401 to be able to detect a binding 
effect.
Merrifield Resin, with its macroporous structure, provides a far greater 
surface area upon which to immobilise peptides of interest.
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Appendix 4
A4.1 Introduction
Integral to the production of a good quality imprinted polymer is 
template removal from the finished product. Of course, the binding sites 
in the finished polymer may have high affinity for their target but if they 
are still occupied by the template included in the manufacturing 
process, this binding affinity will never be seen. In this instance, the 
binding site is not typical of that found in molecular imprinting literature, 
instead being peptide derived from phage display. Therefore, we turn to 
phage display protocols for methods of template removal. In their paper 
(Rozinov and Nolan, 1998), the dye is immobilised to a solid support 
while the peptide is in situ on the phage particle and the authors elute 
bound phage from their target with a glycine buffer.
However, it was found that glycine buffer did not disrupt binding when 
the peptide was immobilised to Merrifield Resin and the dye was free in 
solution. Arginine buffer is used in protein purification and antibody 
elution (Ejima et al., 2005, Arakawa et al., 2007). With this in mind, 
several washing procedures were employed.
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A4.2 Methods
TR401-functionalised resin was incubated in a SR solution (16.5pM) 
and then sonicated in either arginine buffer (1M, pH4.3) or ethanol. 
Resulting resins were then observed under Leica SP5 confocal laser- 
scanning microscope equipped with argon and helium/neon laser and a 
63xoil-immersion objective. The bright-field and fluorescence frames 
were then processed as side-by-side images using the Leica LAS AF 
software. The resins were then re-exposed to SR and observed once 
more under the microscope in an effort to observe whether rebinding 
could occur, i.e. whether the washing regimen damages the binding 
ability of the peptide-functionalised resin.
A4.3 Results
The following series of confocal microscopy images each comprise a 
fluorescence-only image, a bright-field image, and an overlay.
Table 10: Key to confocal microscopy images presented in Figures 87-90.
Fluorescence
Image
Bright-field
Image
Overlay KEY
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Figure 87: Peptide-functionalised resin: Unexposed resin (A), exposed to sulforhodamine 
(B), sonicated in arginine buffer (C), re-exposed to sulforhodamine (D) observed under 
Leica SP5 confocal laser-scanning microscope.
The first experiment in this series observes the washing effect of 
sonication in arginine buffer (pH 4.3) in an attempt to remove bound SR 
from peptide-functionalised Merrifield Resin, shown in Figure 87. The 
first set of images (A) show peptide-functionalised resin that had not 
been exposed to SR. Some minimal autofluorescence is observed. The 
second set of images (B) show the same resin after exposure to SR 
(330nM in water, rinsed twice with distilled water). The third images (C) 
show the same resin after sonication for 5 minutes in arginine buffer. In
an effort to demonstrate re-binding of SR, the fourth set of images (D) 
was a re-exposure of this resin to SR solution. Figure 88 shows the 
same treatments using non-functionalised resin.
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Figure 88: Non-functionalised resin: Unexposed resin (A), exposed to sulforhodamine 
( B), sonicated in Arginine buffer (C), re-exposed to sulforhodamine (D) observed under 
Leica SP5 confocal laser-scanning microscope.
Figure 89 and Figure 90 show a repeat of the previous experiment with 
an ethanol wash in place of arginine.
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Figure 89: Peptide-functionalised resin: unexposed resin (A), exposed to sulforhodamine 
(B), sonicated in ethanol (C), re-exposed to sulforhodamine (D) observed under Leica 
SP5 confocal laser-scanning microscope.
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Figure 90: Non-functionalised resin: unexposed resin (A), exposed to sulforhodamine 
(B), sonicated in ethanol (C), re-exposed to sulforhodamine (D) observed under Leica 
SP5 confocal laser-scanning microscope.
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Appendix 5
Peptide TR401 Stability
Upon receipt of TR401 from manufacture at Severn Biotech, it was 
assessed using high performance liquid chromatography (HPLC) and 
Matrix-assisted laser desorption/ionisation-time of flight mass 
spectrometry (MALDI-TOF MS).
Figure 91: MALDI-TOF scan of TR401 as supplied by Severn Biotech.
Figure 91 shows the mass spectrum of TR401 direct from Severn 
Biotech, stored at -20°C under desiccation. Figure 92 shows the same 
sample after being put through three freeze-drying cycles.
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AJA1 2 (0.066) Sm (SG, 1x9.00); Cm (2:17)
Figure 92: MALDI-TOF scan of TR401 after three freeze-drying cycles.
Figure 91 and 92 indicate that there may already be some 
fragmentation of the peptide even upon receipt from manufacturer, as 
the molecular weight of TR401 is approximately 1900Da. There is also 
some evidence of dimerisation as there is a small peak visible at 
approximately 3800Da.
TR401, as supplied from Severn Biotech, was dissolved in a range of 
solvents and assessed using HPLC. The stationary phase consisted of 
a C18 column, with gradient mobile phase constructed using H2O + 
0.1% trifluoroacetic acid (TFA) and acetonitrile (MeCN) + 0.1%TFA, 
initially 95:5 for 35 minutes, then 0:100 until 50 minutes. Peptide was 
detected with UV absorbance at 220nm and 254nm.
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Figure 93: HPLC trace of TR401 from C18 column using gradient mobile phase H2O + 
0.1% trifluoroacetic acid (TFA) and acetonitrile (MeCN) + 0.1%TFA, initially 95:5 for 35 
minutes, and then 0:100 until 50 minutes.
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Table 11: Peak areas associated with TR401 in a range of solvents as assessed by HPLC.
Treatment Peak 1 (%) Peak 2 (%) Peak 3 (%)
Water 34.7 16.2 44.2
PBS 32.8 18.6 48.1
TBS 48.2 12.3 38.9
Ethanol 45.6 17.1 37.1
Methanol 52.6 19.0 27.8
Methanol/water
50:50
56.5 19.2 23.0
“Peptides containing tryptophan may show some peak splitting on 
HPLC because this bulky group can affect the secondary structure, 
causing the peptide to exist in different conformers in solution, which 
have slightly different retention times on HPLC.”
Dr. A. Smithson (Peptide chemist, Severn Biotech) 
Personal Communication.
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Appendix 6
Polymerisation data
Figures 94-101 show the binding isotherms for which Kd and Bmax are 
summarised in Chapter 4 (Table 4&5 in Section 4.3.4).
Figure 94 and Figure 95 show the result of the SR binding assays 
carried out with peptide-functionalised non-imprinted polymer (P-NIP) at 
varying polymerisation times. Figure 96 and Figure 97 show the 
equivalent data for the peptide-functionalised molecularly imprinted 
polymer (P-MIP).
The remaining figures are the result of the non-peptide treatments, both 
imprinted and non-imprinted.
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Figure 94: Sulforhodamine-binding assay performed using Peptide-functionaiised, non- 
imprinted polymer (P-NIP) -  Polymerisation times ranging from 0 to 15 minutes.
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Figure 95: Sulforhodamine-binding assay performed using Peptide-functionalised, non- 
imprinted polymer (P-NIP) -  Polymerisation times ranging from 20 minutes to 120 
minutes. TR401-functionalised resin with no polymerisation is included for reference.
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Figure 96: Sulforhodamine-binding assay performed using Peptide-functionalised 
molecularly imprinted polymer (P-MIP) -  Polymerisation times ranging from 0 to 15
minutes.
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Figure 97: Sulforhodamine-binding assay performed using Peptide-functionalised 
molecularly imprinted polymer (P-MIP) -  Polymerisation times ranging from 20 minutes 
to 120 minutes. TR401-functionalised resin with no polymerisation is included for
reference.
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Figure 98: Sulforhodamine-binding assay performed using Molecularly Imprinted 
Polymer (MIP) [No peptide] -  Polymerisation times ranging from 0 to 15 minutes.
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Figure 99: Sulforhodamine-binding assay performed using Molecularly Imprinted 
Polymer (MIP) [No peptide] -  Polymerisation times ranging from 20 minutes to 120 
minutes. TR401-functionalised resin with no polymerisation is included for reference.
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Figure 100: Sulforhodamine-binding assay performed using Non-imprinted Polymer (NIP) 
[No peptide, no template] -  Polymerisation times ranging from 0 to 15 minutes.
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Figure 101: Sulforhodamine-binding assay performed using Non-imprinted Polymer (NIP) 
[No peptide, no template] -  Polymerisation times ranging from 20 minutes to 120 
minutes. TR401-functionalised resin with no polymerisation is included for reference.
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